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Abstrac t 
The purpose of the current project is to illustrate the application of advanced statistical 
techniques to address research questions about depression and anxiety in patients with an 
acute coronary syndrome (ACS). The first study, using data from 100 patients who were 
randomized into a clinical trial of cognitive behavioral therapy, used bivariate mixed 
models to determine trajectories of depression and anxiety after an ACS, to examine the 
effects of cognitive behavioral therapy (CBT) on depression and anxiety, and to 
determine if anxiety and depression symptoms change at the same rate with CBT 
treatment as indicated by joint modeling o f these two psychiatric disorders. The findings 
suggest that depression and anxiety are highly correlated and persistent in patients with 
an ACS both at baseline and over time. The intervention used in the present investigation 
does not appear to uncouple the association between anxiety and depression, suggesting 
that CBT has comparable effects on both psychiatric disorders.   
          The second study used latent transition analysis to identify symptomatology 
profiles of depression, anxiety, and functional impairment in patients with an ACS, 
describe changes over time (two, three and six-month follow-up) in patient’s acute 
symptom profiles, and determine if patients receiving CBT showed signs of remission in 
depression, anxiety and impaired function earlier than patients that received usual care. A 
three-class model was selected to identify and describe these acute symptom profiles. 
One class was characterized by patients with both psychiatric disorders and impaired 
function, the second by patients with psychiatric disorders but normal function, and the 
third by patients with anxiety but without depression, and having normal function. There 
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was moderate improvement in depression, anxiety and functional status for control 
patients, but this improvement was less evident than in the treatment group.  Women 
showed a better response to CBT than men. 
         The third s tudy used latent class and latent transition analysis to determine 
symptom profiles of depression and anxiety in patients with an ACS us ing the Hospital 
Anxiety Depression Scale; a secondary study goal was to examine the effects of age and 
gender on these symptom patterns. A two-class model was selected to describe 
depression and anxiety symptomatology profiles. Class I (76% of patients at baseline) 
was labeled as “severe depression and some anxiety” whereas Class II (24% of patients at 
baseline) was labeled as “mild depression and distress anxiety”. More than 70% of older 
patients continued to have severe depression and anxiety at follow-up and a large 
proportion of these patients who reported mild depression and anxiety at baseline showed 
worsening o f symptoms at follow-up. The current study demonstrates that patients with 
depression and anxiety after an ACS can be identified on the basis of the symptoms that 
they present. This is particularly important to identifying individuals at potential risk for 
developing clinical complications after an ACS. 
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Preface:  
Depression and anxiety in patients with an acute coronary syndrome (ACS) are a 
significant and growing public health and c linical concern.  Very few studies have, 
however, examined changing patterns of depression and anxiety over time in patients 
with an ACS. F urthermore, the majority of published s tudies have failed to examine the 
joint effects of depression and anxiety. This is particularly important to examine since the 
majority of patients with an ACS report symptoms of both disorders.     
         The proposed study is designed to address these gaps, and will longitudinally assess 
patterns and predictors of depression and anxiety in the six-month period following an 
ACS event using advanced statistical techniques. The results may allow clinicians to 
better diagnose and treat anxiety and depression. Determining the prevalence rates of 
depression and anxiety after hospitalization for an ACS, and factors associated with both 
mood disorders and their changing patterns over time, should translate into improved 
long-term outcomes including enhanced medication compliance, be tter quality of life, 
and improved daily functioning in patients with an ACS.   
Chapter I 
         The acute coronary syndromes (ACS), including acute myocardial infarction and 
unstable angina, are a common and prevalent disease, affecting approximately 16 million 
Americans in the last year 1-4. Depressive illness, ranging from dysthymia to major 
depressive disorder (MDD), and anxiety are highly prevalent in chronically, medically- ill 
individuals, including those with an ACS, than in the general population 1-3, 5. Patients 
with an ACS represent a population at increased risk for depression and anxiety, although 
both psychiatric disorders are often underdiagnosed and less than optimally treated in 
these high risk patients 6. The occurrence of depression and anxiety in patients with an 
ACS presents pr imary care clinicians with diagnostic and operational challenges.  
Addressing these challenges is of considerable public health and clinical interest because 
depression and anxiety have a significant impact on patients with an ACS and are 
associated with increased morbidity, declines in quality of life and function, and all-cause 
as well as cardiac related mortality1. 
         The majority of research published to date describing the association of an ACS 
with anxiety and depression has been carried out during a patient’s acute hospitalization 
or during the immediate post-hospitalization period. Few studies have, however, 
examined changing patterns of depression and anxiety in patients after hospitalization for 
an ACS and the factors associated with change in these psychiatric disorders over time 7-
9. Furthermore, the majority of published studies have failed to examine the joint effects 
of depression and anxiety7-11. This is particularly important to examine since the majority 
of patients with an ACS report symptoms of both disorders11.  
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         The overall goa l of this dissertation is to de termine and model the joint effects of 
depression and anxiety, and the factors associated with improvement in the symptoms of 
these two psychiatric disorders, in patients with an ACS over time. Data to support this 
goa l and address study hypotheses (below) will come from a two-arm randomized 
controlled trial with over 250 observations of patients with an ACS who received phone-
based cognitive behavioral therapy to modulate the risk of depression and anxiety. 
Together, bot h the counselors and patients identified barriers to adjustment to their 
medical illness and worked on strategies to address these barriers16. In summary, the 
specific aims of this dissertation include the following:  
A. Specific Aims: 
 Aim 1: Depression and Anxiety after an Acute Coronary Syndrome: a Bivariate 
Mixed Model Approach: The objectives of this study were to determine trajectories of 
depression and anxiety after an ACS, to examine the effects of cognitive behavioral 
therapy (CBT) on depression and anxiety, and to determine if anxiety and depression 
symptoms change at the same rate with CBT treatment as indicated by joint modeling o f 
these two psychiatric disorders.    
Clinical Implications of Aim 1: The estimate for the response to an intervention using 
CBT will be higher when modeling anxiety and depression separately (conditional 
growth) than in the latent growth mode l in which depression and anxiety serve as the 
indicators of a psychiatric disorder.  Although correlated, each of these indicators may 
provide unique and independent information to the measurement of a psychiatric disorder 
after modeling the overlapping effects of the two indicators. 
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Aim 2: Identifying Classes of Response to Treatment of Depression, Anxiety and 
Function in Patients After an Acute Coronary Syndrome : The objectives of this study 
were to (1) identify symptomatology profiles of depression, anxiety, and functional 
impairment among patients with an ACS; (2) describe change over time in 
symptomatology profile; and (3) determine if patients receiving CBT showed signs of 
remission in depression, anxiety and impaired function earlier than patients that received 
usual care. In add ition, the assoc iation between symptomatology profile and age, gender, 
and length of stay in the hospital was examined.   
Clinical Implications of Aim 2: Examining transitions between symptomatology 
profiles provides a detailed look a t change over time that is difficult to obtain using more 
traditional data analytic approaches. This statistical approach assists in clarifying periods 
during which an intervention is most likely to be effective.   
Aim 3: Profiling Symptoms of Depression and Anxiety in Acute Coronary 
Syndrome Patients Using Latent Class and Latent Transition Analysis: To determine 
the symptom profiles of depression and anxiety in patients with an ACS using t he 
hospital anxiety and depression scale (HADS). A secondary study objective was to 
examine the effects of age and gender on these symptom pa tterns. 
 Clinical Implications of Aim 3: Identifying symptom profiles of depression and anxiety 
are useful first step towards developing more tailored interventions and improved 
treatment strategies.  The results of the current study stress the importance of the 
assessment of depression and anxiety and follow-up o f patients after an ACS 
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         To accomplish these specific aims, I will conduct an analysis of longitudinal data 
collected from a randomized controlled trial at two coronary care units at university 
hospitals in Boston, MA, from September, 2001 to August, 2003.   
         One hundred English-speaking patients 35 years and older with symptoms of 
depressive illness or anxiety, as indicated by a score of 7 or higher on either of the 
subscales of the Hospital Anxiety Depression Scale (HADS), who had not received 
mental health care in the prior 3 months, ps ychoactive drug use during t he past year, and 
a diagnosis of substance abuse during the past year were enrolled. The trial intervention 
consisted of a series of cognitive treatment sessions that helped patients identify and 
manage the challenges of living with a chronic condition, while patients in the control 
group received information on coping with cardiac illness (see more details on C.3). In 
add ition, information was collected by telephone interviews for the following scales: the 
Hospital Anxiety and Depression Scale (HADS), home and work function, and patient’s 
perceptions of their health and state anger. Information was collected at baseline 
(approximately one month following hospital discharge for an ACS) and at 2, 3 and 6 
months after trial enrollment. Information collected from medical records, at baseline 
only, included demographic characteristics, presence of comorbid conditions, history and 
characteristics of an ACS, and treatment practices and interventions utilized in patient 
management (see table 1.2 for details on study sample). 
         The results of this dissertation will provide insights into the prevalence of 
depression and anxiety in pa tients with an ACS over time and other characteristics 
associated with these disorders. This dissertation will also be utilized to develop tailored 
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interventions to improve the symptoms of depression and anxiety in patients with an 
ACS. 
B. Background and Significance:  
B.1 Overview of acute coronary syndrome (ACS) 
The acute coronary syndromes (ACS), including myocardial infarction, and 
unstable angina, are a major cause of morbidity and mortality worldwide1–4. According to 
recent figures, in the United States approximately 14 million people have a prevalent 
ACS, with more than 1 million people experiencing an acute myocardial infarction or 
fatal episode of coronary heart disease each year; more than 466,000 deaths are attributed 
to an ACS annually21.  The ACS not only impact morbidity and mortality, but also affects 
quality of life, functional ability and performance at work 4.  
B.2. Overview of depression and anxiety 
         Major Depressive Disorder (MDD) is a syndrome that includes emotional, 
cognitive, behavioral and somatic regulation disturbances 28. It is usually characterized by 
sadness and anhedonia (inability to experience pleasure), but often includes profound 
abnormalities on cognition and neurovegetative, or physiological function 27. The 
Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) bases the diagnosis of a 
mood disorder on the duration of symptoms, the number of symptoms present, and the 
presumed etiology of the syndrome. Major depressive disorder is characterized by the 
presence of a depressed mood or the loss of pleasure/interest for most of the day during 
two weeks, plus clinically significant impairment in at least five of the following areas: 
appetite or weight disturbance, sleep disturbance, fatigue or loss of energy, psychomotor 
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agitation or retardation, feelings of worthlessness, poor concentration, and recurrent 
thoughts of death, including suicidal ideation or attempts that have persisted for at least 
two weeks13.        
         In contrast, dysthymia is reserved for a cluster of symptoms that have persisted over 
a longer period of time. The number of symptoms (at least two) needed to diagnose 
dysthymia is less than for MDD, but persistent depressed mood has to be present for at 
least two years 13.  On the other hand, t he diagnos is of a mood disorder, or depressive 
disorder due to a general medical condition, describes a significant disturbance in mood 
that is directly related to the presence of a medical condition known to cause depression, 
as long as the mood symptoms do not meet criteria for other DSM-IV categories of 
depression 13.      
         Depressive disorders are relatively common in the general population. The recently 
completed National Comorbidity Survey Replication survey, an upda ted version of the 
National Comorbidity Study, a representative epidemiological study of psychiatric 
conditions in the general population, reported twelve-month prevalence rates of MDD 
and dysthymia of 6.7% and 1.5%, respectively in the general population aged 18 years 
and older 23. The lifetime prevalence was 16.6% for MDD and 2.5% for dysthymia 24. 
         Additionally, depression imposes an important economic burden on the United 
States health care system. Cost-of- illness estimates for the treatment of depression were $ 
83 billion in the United States in 2000. Of this amount, 62% were work-related costs (e.g. 
absenteeism), and one third was attributed to direct medical costs 25.  
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         Anxiety disorders, including panic disorder, generalized anxiety disorder (GAD), 
specific phobias, and separation anxiety disorder, were the most prevalent lifetime 
psychiatric disorders reported in the National Comorbidity Survey-Replication survey. A 
lifetime prevalence rate of 29% for anxiety disorders, in general, and a 6% lifetime 
prevalence rate for GAD have been estimated 24; this study also reported a prevalence 
estimate of GAD within the past 12 months of approximately 3%. The original National 
Comorbidity survey reported that 58% of respondents with GAD within the past 12 
months also met the criteria for MDD within the last 12 months 34. Generalized anxiety 
disorder is characterized by feelings of threat, restlessness, irritability, s leep disturbance, 
tension and symptoms such as palpitations, dry mouth, and sweating 35. 
B.3. Depression and anxiety in patients with an ACS  
         Major depression, minor depressive disorders, and anxiety are all independent risk 
factors for higher mortality rates and diminished quality of life in patients with an ACS 43, 
44.  Moreover, after a myocardial infarction, patients with depression have a 3.5 -fold 
increase in cardiovascular mortality relative to pa tients without depression 27. After an 
ACS episode, depression and anxiety appear to inhibit recovery, decrease medication 
compliance, and have a negative impact on soc ial func tioning and capacity to perform 
activities of daily living. Additionally, patients with an ACS and symptoms of depression 
and anxiety experience longer hospital stays and worse symptomatic (physical, mental or 
both) and social outcomes than those without these conditions14, increasing the economic 
burden on the health care system.       
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         Even though most of the studies reported higher mortality rates, higher morbidity 
and diminished quality of life in patients with an ACS with anxiety and/ or depression, 
there are some inconsistencies in the literature regarding the association of depression 
and anxiety as risks factors for increased mortality in patients with an ACS. Some studies 
clearly demonstrated higher mortality and morbidity rates in patients with an ACS with 
anxiety and/ or depression whereas a few failed to find an association 8-12. Two studies 
reported that the symptoms of depression and anxiety were not associated with higher 12-
month mortality in patients with an ACS 8, 12.  
           On the other hand, there are an extremely limited number of studies that have 
assessed the joint effects of depression and anxiety in patients with an ACS and the 
impact of these conditions on ACS related outcomes 9- 11, 17-19. Most studies have 
examined the prevalence of depression and anxiety separately. These studies reported a 
range in the estimated prevalence of depressive symptoms in patients with an ACS from 
8 to 47% and a range of clinically diagnosed depression from 11 to 39%. 5-12. Published 
estimates of anxiety symptoms in patients with an ACS range from 10 to 25% 33-37. These 
broad ranges of depression and anxiety estimates are due to the different instruments used 
to assess both psychiatric disorders and also due to the different time periods when the 
disorders were assessed. 
In summary, it is important to be tter understand the joint effects of depression and 
anxiety, and determine if they are associated with worse outcomes than anxiety and 
depression alone, in patients with an ACS. It is also of considerable importance to 
determine the prevalence of depression and anxiety in patients with an ACS and their 
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joint effects on compliance with medication, morbidity, and mortality in these high-risk 
patients. Better understanding of these issues can lead to the development of both 
pharmacological and psychosocial treatments for anxiety and depression among patients 
with an ACS that can improve patient’s prognosis and quality of life 42, 45.   
B.3.1. Limitations of previous studies 
While it is clear that depression and anxiety are common among patients with an 
ACS, there are a wide range of estimates of the extent of the problem. The studies 
reviewed share similar weaknesses. Most studies evaluated pa tients with an ACS for 
depression and anxiety during the acute hospitalization period 9, 11, 17.  Prevalence rates of 
depressive disorders and anxiety are likely to be the highest during this period and 
decline subsequently over time.  
Few studies had prolonged follow-up o f their study samples to assess prevalence 
and changes in the pattern of symptoms of depression and anxiety over time. This is 
important to evaluate for the following reasons: First, two studies demonstrated that 
higher sustained levels of anxiety and depression over time are associated with low 
medication compliance, poorer medical prognosis and increased mortality 5, 36.  Second, 
the lack of data makes it difficult to estimate the ongoing clinical needs of patients with 
an ACS and the overall public health impact of depression and anxiety in these high risk 
patients. Among the few studies that have add ressed the longitudina l pa tterns of anxiety 
and depression symptoms, inconsistencies have been found.  One study followed 37 
patients that were admitted into the intensive care unit after a myocardial infarction in the 
UK during 1998 (mean age: 62 years, 73% men). Researchers assessed these patients for 
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symptoms of anxiety and depression when they were admitted into the hospital and three 
months later. The symptoms of depression improved significantly over time, while no 
changes in anxiety symptoms were apparent 19. The average HADS anxiety scores 
decreased by -0.4 po ints (p-value = 0.69) whereas the average HADS depression scores 
decreased by -2.13 po ints (p-value=P <0.05) 19. Another study in Norway followed more 
than 23,000 patients from 1995-1997(mean age: 50 years, 45% men). The results  suggest 
that gender differences in the variation of symptoms over time; women showed an 
increased risk for both anxiety and depression in the first 2 years post-myocardial 
infarction (MI), followed by a significant reduction in these symptoms. In contrast, the 
risk for depression in men increased after 2 years post-MI (from 1.36 to 1.61) 11. No 
significant trends were found in men (adjusted OR= 1.2, P = 0.3 for depression and 
adjusted OR=1.03, P = 0.92 for anxiety) 11. A third study, where 347 patients (mean age: 
63 years;  73 % men) were assessed for depression and anxiety after a MI in the UK 
during 1995 has demonstrated that there was an improvement in the depression and 
anxiety scores at 3 month follow-up, but there was little overall or individual change after 
that time 10. Approximately 40 % of patients met the criteria for anxiety during hospital 
admission and 18% met criteria for depression. There were improvements in mean scores 
for anxiety and depression between the time of the baseline and 3-month assessments in 
patients 10.  Finally, in a fourth study, researchers at two general hospitals in the UK 
assessed 288 MI patients (mean age: 62 years ; 75 % men) for symptoms of depression 
and anxiety using the Beck Depression Inventory (BDI) and the State–Trait Anxiety 
Inventory (STAI) in hospital, 2–15 days following MI, and 4 and 12 months 
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subsequently. The rates of anxiety and depression increased following hospital discharge 
and remained elevated during t he year after the MI occurred, in approximately one third 
of study participants 12.  During hospitalization, 32 and 26% of the patients reported 
symptoms of depression and anxiety, respectively. The 4- and 12-month prevalence rates 
were 38 and 37% for depressive symptoms, and 42 and 40% for anxious symptoms, 
respectively 12.  
All of these studies share a common weakness, which is that they have failed to 
examine the joint effects of depression and anxiety in patients with an ACS over time. 
This is particularly important to examine since the majority of patients with an ACS 
report symptoms of both psychiatric disorders and there is an important overlap of 
anxiety and depressive symptoms in patients with an ACS over time.  An important 
limitation of the studies reviewed is that none compared profiles of responders vs. non-
responders to the behavioral intervention. This information is very important since the 
response to an intervention is likely to be dependent on the patient’s age, gender, leve l of 
education and other important factors. My dissertation will specifically address these 
gaps in the literature to improve the diagnosis and treatment of depression and anxiety in 
patients with an ACS. These results would translate into improved long- term outcomes 
including enhanced medication compliance, better quality of life, and improved da ily 
functioning in patients with an ACS.   
B.4 Complexity of diagnosing depression and anxiety in patients with an ACS  
There are no evidence-based guidelines that specify how to assess depression and 
anxiety in patients with an ACS, including a lack of recommended assessment scales and 
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time-frame to conduct these assessments.  As evidenced by the wide range of prevalence 
estimates, diagnosing depression and anxiety in patients with an ACS is a complex task. 
The diagnosis of depression and anxiety is usually ba sed upon self- reported patient 
symptoms.  Symptoms of an ACS, such as lack of energy or difficulty sleeping, overlap 
with symptoms of depression and anxiety. Thus, patients with an ACS often have cardiac 
symptoms that meet diagnostic criteria for depression and/or anxiety 6. This lack of 
specificity in symptoms indicates a need for screening and diagnostic assessment tools 
for use in clinical practice that are able to differentiate between cardiac and psychiatric 
symptoms.  Failure to differentiate the origin of symptoms could result in identifying 
false positive cases of depression, if the symptoms are incorrectly ascribed to a 
psychiatric disorder, resulting in unnecessary and even harmful medication treatment in 
medically complex patients.  Improving diagnostic methods for depression and anxiety in 
patients with an ACS could translate into be tter treatment for these patients, resulting in 
improvements in long-term outcomes including enhanced medication compliance, quality 
of life, and improved functioning.  
B.4.1 Common depression and anxiety assessment tools 
         Several instruments have been used to measure depressive symptoms in patients 
with an ACS (Table 1). Some of the more common instruments include: the  Beck 
Depression Inventory (BDI), Hamilton Depression Rating Scale (Ham-D), Patient Health 
Questionnaire (PHQ-9), the Primary Care Evaluation of Mental Disorders (PRIME-MD),  
Symptom Checklist-90 (SCL-90), Center for Epidemiologic Studies Depression (CES-
D), Hospital Anxiety  and Depression Scale (HADS) and the Geriatric Depression Scale 
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(GDS) 30-31. Common limitations of these scales are, however, that they primarily focus 
on the somatic symptoms of depression, making it very difficult to differentiate 
symptoms related to depression from symptoms related to an ACS. The BDI, for 
example, inc ludes items that focus on somatic symptoms such as lack o f energy or 
difficulty sleeping that may overlap with several cardiac symptoms. While the PHQ-9 is 
easy to administer, and takes less than five minutes for patients to complete, 31 it also 
does not differentiate between symptoms. Many of the other measures are quite lengthy 
and not practical for administration in clinical settings. The best-known anxiety 
assessment instrument used in research is the Hamilton Rating Scale for Anxiety; this 
instrument, however, includes information about too many physical symptoms and is not 
simple to use requiring a trained interviewer to administer the scale 35.  With the 
exception of the HADS, no survey inc ludes sub-scales to differentiate depression and 
anxiety.   
The HADS overcomes several of the barriers described for measuring anxiety and 
depression in patients with an ACS. First, it measures both anxiety and depression 
independently. The HADS is both sensitive and specific in identifying pathological 
anxiety.  The HADS also overcomes the limitation of misdiagnosis with measurement 
tools that assess somatic depression symptoms, because of shared ACS symptoms, by 
measuring cognitive depression and anxiety constructs. As such, it has resulted in lower 
estimated prevalence rates for depression in cardiac patients than the BDI 32. In addition, 
it is easily administered in clinical settings, taking five minutes or less to complete.31  
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In summary, there are a wide range of possible scales used to assess depression 
and anxiety in patients with an ACS. The HADS overcomes many of the limitations of 
these scales and is an appropriate instrument to measure anxiety and depression in 
patients with an ACS.  
 
Table 1.1: Instruments utilized to assess depression and anxiety in patients with an ACS 
 
The Hospital Anxiety Depression Scale (HADS); Patient Health Questionnaire (PHQ-9), the Primary Care 
Evaluation of Mental Disorders (PRIME-MD), Symptom Checklist-90 (SCL-90); Hamilton Depression 
Rating Scale (Ham-D); Beck Depression Inventory (BDI); Beck Anxiety Inventory (BAI);  Hamilton 
Depression Rating Scale (Ham-A)  
 
 
B.5. Significance of the proposed study 
         In summary, depression and anxiety in patients with an ACS is a significant and 
growing public health and c linical concern.  The majority of research findings published 
to date describing anxiety and depression in patients with an ACS were conducted during 
hospitalization for the ACS event or in the immediate post-hospitalization period. Very 
few studies have examined changing patterns of depression and anxiety over time in 
Instrument Number  
of items 
Time to 
complete  
Items scoring 
range  
Administration Limitations 
HADS 7 5’ 0-3 (>8) Self-report Does not include  
DSM-IV criteria 
PHQ-9/PRIME-
MD 
9 5’ 0-3 (>10) Self-report Designed for primary care 
use 
SCL-90 90 12-15’ 0-4 Self-report Research-oriented -
psychiatric & non-psych 
HAM-D 17 15-20’ 0-2/0-4 (>18) Trained-
interviewer 
Items overlap w/ somatic 
signs.  
BDI 21 5-10’ 0-3  (>10) Self-report Does not include  
DSM-IV criteria 
BAI 21 5-10’ 0-3  (>10) Self-report Does not include 
 DSM-IV criteria 
HAM-A 14 10’ 0-4 (>18) Trained-
interviewer 
Items overlap w/ somatic 
signs 
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patients with an ACS 7-9. Furthermore, the majority of published studies have failed to 
examine the joint effects of depression and anxiety7-11. This is particularly important to 
examine since the majority of patients with an ACS report symptoms of both disorders11.     
         The proposed study is designed to address these gaps, and will longitudinally assess 
patterns and predictors of depression and anxiety in the six-month period following an 
ACS event. The results of the proposed study will provide much needed insights into this 
area of relative neglect by clinical researchers. This information will allow clinicians to 
better diagnose and treat anxiety and depression. Therefore, it will help to prevent the 
complications associated with depression and anxiety in patients with an ACS such as 
increased morbidity, mortality due to cardiovascular illness, and all cause mortality. 
Determining the prevalence rates of depression and anxiety after hospitalization for an 
ACS, and factors associated with higher prevalence of both psychiatric disorders and 
their changing patterns over time will translate into improved long-term outcomes in 
these high risk patients.   
 
C. Methods:  
C.1. Study Design 
         The proposed study will be a longitudinal analysis of data from a prospective, two-
arm, randomized, controlled trial of telephone counseling intervention in patients with  
depression and anxiety after an ACS supported by funding from the Robert Wood 
Johnson Foundation. The trial compared the intervention condition, cognitive behavioral 
therapy (CBT), to usual care for the treatment of psychological distress in patients 
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surviving a recent ACS. The unit of randomization used in this study was the individual 
patient. Patients randomized to the CBT arm received the intervention according to a 
standard protocol. Although the recruitment process began with patient contact in the 
hospital, recruitment did not occur until one month following hospital discharge to allow 
for spontaneous resolution of depression and anxiety symptoms. Patients were screened 
at one month following discharge and those meeting predefined inclusion criteria were 
consented and assigned randomly to experimental or control status. Baseline survey 
assessments (within 30 days of hospital discharge) included the Primary Care Evaluation 
of Mental Disorders (PRIME-MD) and the Hospital Anxiety and Depression Scale 
(HADS), the primary outcome measure. The HADS and other study instruments were 
also administered at 2, 3, and 6 months after baseline enrollment. The study design 
therefore, is a randomized controlled trial with four waves of data corresponding to 
baseline and three follow-up time points.   
C.2. Study Setting and Sample 
         Patients for this study were recruited from two coronary care units at the Health 
Centers Division (HCD) of Harvard Pilgrim Health Care, which is one of the largest 
Health Maintenance Organizations (HMO) in New England, serving nearly 300,000 
individuals in and around Boston, MA. Patients were recruited from September, 2001 to 
August, 2003. The HCD provides medical services to a diverse patient population. 
Information on race and ethnicity is not uniformly collected, although these variables are 
recorded for a majority of patients from medical records. According to these data, 
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approximately three quarters of the patients are Caucasian, 16% African-American, 3% 
Hispanic, 1% Asian, and 5% other or unknown.  
C.2.1 Patient inclusion/exclusion criteria  
         This study targeted for recruitment patients with mild to moderate levels of 
depression and or anxiety. Patients were eligible for trial entry based on the following 
eligibility requirements: 
• Have an index diagnos is of an ACS, defined as unstable angina pectoris or acute       
myocardial infarction 
• Be between 35 to 64 years of age 
• Have a depression and/or anxiety score of 7 to 15 on the HADS, consistent       
with mild to moderate depression and/or anxiety   
• Ability to speak and comprehend English 
• Have access to a telephone 
Patients were excluded if they met any of the following criteria: 
• Exhibit any severe developmental delay or major psychological disorders 
• Actively use illegal drugs or consume large amounts of alcohol daily  
• Currently receive care from a mental health provider 
• Are found to have severe depression or anxiety, indicated by a score of  
           greater than 15 on either the HADS depression or anxiety scale, at time of  
      enrollment phone call.  
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Figure 1.1: Enrollment and selection of participants 
 
 
C.2.2. P atient Identification, Recruitment and Informed Consent 
         Figure 2 describes the patient identification, recruitment and enrollment algorithm 
for this trial. The study targeted for recruitment patients with mild to moderate levels of 
depression and/or anxiety who were hospitalized for an ACS. Potentially eligible patients 
were identified through electronic encounter data and hospital census information. The 
International Classification of Diseases Ninth Edition (ICD-9) diagnosis codes that were 
used to identify patients for this study included: 410.xx Myocardial Infarction (all codes 
410.1 through 410.9), 411.1 Unstable Angina, and others associated with an ACS.  
Patient recruitment began during the index hospitalization at two Boston teaching 
hospitals. After chart review, the research nurse contacted the patient’s attending 
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physician for permission to approach the patient (Figure 2) with study information. The 
research nurse then approached the eligible patient during the hospital stay. If the patient 
expressed interest and chose to participate, the informed consent form was signed at that 
time. Otherwise, the consent forms and a self-addressed, postage-paid envelope were 
provided. Informed consent could be obtained for up to 30 days following hospital 
discharge. Once patients consented, the study coordinator administered the 14- item 
HADS by phone to assess symptoms of anxiety and depression. Subjects with scores 
between 7 and 15 on either the anxiety or depression scale were enrolled and randomized 
to the intervention or usual care. Randomization resulted in balanced intervention and 
control groups. Participants were largely older patients (mean age patients: 60.7 vs. 
controls: 59.9) and males (almost 70%), reflecting the descriptive epidemiology of 
coronary heart disease. The study coordinator was responsible for ensuring that patients 
met all of the inclusion/exclusion criteria for the study and completed all 
baseline/screening forms.  The institutional review boards of the participating 
organizations reviewed and approved the study protocol.   
 
C.3. Intervention 
C.3.1.Intervention Group 
         The intervention was a cognitive treatment that helped patients identify and manage 
the challenges of living with a chronic condition. It was goal oriented, t ime limited, and 
issue focused. It was based on other telephone interventions targeted to treat depression 
by modulating the risk of depression, anxiety, and functional decrements through 
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improved adjustment to illness 20. Sessions lasted for approximately 30 minutes and were 
conducted by doctoral- level clinicians (a psychiatrist, clinical psychologist, and internist). 
Patients were expected to complete six sessions, but allowed to participate in as few as 
three if the therapist and patient agreed that all eight issues set forth during treatment 
were reviewed, and that treatment goals were reached. The first contact reviewed eight 
fears commonly experienced by those living with chronic medical conditions: loss of 
control, loss of self- image, dependency, stigma, abandonment, anger, isolation, and fear 
of death 38. In sessions two through six, the counselor reviewed progress toward goals 
with reinforcement and encouragement. A session log tracked the issues reviewed in each 
session. At weekly meetings, the counselors reviewed cases and notes with the research 
team to monitor fidelity to the intervention.  
C.3.2. Control Group 
         Patients randomly assigned to the control group received a booklet on coping with 
cardiac illness typical of those given at hospital discharge and were instructed to contact 
their primary care physician if they experienced any warning signs of depression. They 
were advised to continue follow-up with their primary care and specialist physicians.  
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Table 1.2: Baseline demographics characteristics of study subjects by treatment 
status 
Variable Control (N=34) 
Mean (SD) 
Intervention (N=45) 
Mean (SD) 
• Age 60.7 (9.8) 59.9(10.2) 
• HADS Depression Scores 6.5 (3.8) 8.5 (3.6) 
• HADS Anxiety Scores 7.1 (2.9) 8.1 (3.7) 
• Length of stay 3.1 (4.1) 3.6(3.3) 
 Percentage (%) Percentage (%) 
• Cardiac Condition   
Angina 9 9 
Other Ischemic Condition 91 91 
• Major Depression  29 38 
History of Ischemic Heart Disease 47 40 
• Race    
Black 6 7 
White 88 89 
Missing  6 4 
• Gender    
Female 35 31 
 
 
C.4. Measurements 
C.4.1. Longitudinal Data Collection Protocols  
         A data management and research organization with extensive experience in 
management of behavioral health data collected survey data at baseline and at 2, 3, and 6 
months follow-up using interactive voice recognition (IVR). Interactive voice recognition 
is an automated telephone system that speaks to a patient and automatically enters 
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responses into a database by pressing telephone keys indicating their responses to each 
question. Patients are given written instructions about how and when to call into the IVR 
system. This approach minimizes the likelihood of contamination of control patients. 
Those patients who were randomized to the intervention group worked with the study 
coordinator to schedule the first and follow-up 30-minute calls from their counselor.  An 
aggressive follow-up system consisting of reminder postcards, telephone call reminders, 
and re-mailing of questionnaires was undertaken to ensure the highest possible degree of 
complete data. Failure to call into the IVR system to report data triggered a fax to the 
study coordinator after allowing for a 3-day window for the patient to complete the call. 
At baseline, measures collected through the IVR included HADS, function at home and 
work, and self- rated health, and anger. Patients completed only the HADS at each follow-
up contact point (2, 3 and 6 months).   
C.4.2. Indicators of Psychologic Distress: Depression and Anxiety Symptoms  
         Depression and anxiety symptoms were assessed with the HADS. As described in 
section B.4.1., t he HADS overcomes limitations of other assessment tools because it 
measures depression and anxiety independently, and it assesses cognitive constructs, 
rather than somatic constructs, which minimizes the likelihood t hat somatic symptoms of 
an ACS will be attributed to depression. The HADS contains 7 depression and 7 anxiety 
items rated on 4-point Likert scales. Each scale is scored from 0 to 21, with 0 to 3 
considered in the normal range, 4 to 7 subclinical depression, and 8 to 21 ‘‘depressed’’. 
The same criteria and score are used for anxiety. Patients with a score of 7 or higher on 
the depression or anxiety subscale at the postdischarge screening were eligible to 
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participate. The cutoff on the depression and anxiety scales was lenient to maximize 
inclusion of distressed patients, including the upper end of subthreshold depression or 
anxiety (upper limit of 15).   
C.4.3. Demographic and Illness Variables 
         Baseline patient demographic and illness information was retrieved from the 
hospital medical records by the research nurse and study coordinator using a standardized 
protocol. The period of assessment included up to the point of hospital discharge.  Data 
elements were as follows:  
1. Demographics: age, gender and race (black, white or missing).  
2. Comorbidities: history of ischemic heart disease in years  
3. Treatment: cardiac procedures (coronary angioplasty, catheterization, 
coronary artery bypass surgery, stent placement, bypass) and use of 
antidepressants 
4. Severity of Disease: hospital admission and d ischarge dates, length of 
stay, cardiac discharge diagnosis (angina with or without procedure, 
myocardial infarction with or without procedure and other ischemic heart 
disease, with or without an accompanying procedure). 
C.4.4. Retention Plan  
         Methods  to ensure retention included reminder postcards and telephone call 
reminders to ensure the highest possible degree of complete data.  
C.5. Data Entry and Management 
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         Baseline and follow-up data were collected at 2, 3, and 6 months using IVR. 
Medical records were reviewed at baseline to collect information on patient’s 
demographics, comorbidities, treatment, severity of disease and clinical diagnosis of 
depression as described in D.4.3. Data were entered using double data entry into an 
Access Database specially constructed for the study.  Once entered, the data were subject 
to continuous quality control efforts, thereby ensuring a clean final data set appropriate 
for study ana lyses. 
 
C.6 Data Analysis 
C.6.1 Power calculations  
         Latent models are complex due to the multiple partitioning of variance due to 
autocorrelation in repeated measures, random effects, correlation among predictor 
variables as well as the high correlation between anxiety and depression55-57.  Modeling 
the joint effects of depression and anxiety together will give more information than in the 
simpler single outcome model.  Once we have estimated all means, standard deviations 
and the random effect estimates, a post-hoc power calculation will be performed to 
inform the reliability and the strength of the inferences de rived from the growth models.  
C.6.2 Statistical software 
         SAS version 9.1.3 software will be used for data analysis. Recently released SAS 
macros and procedures will be employed for the latent class trajectory models.  
C.6.3 Detailed statistical analysis for the different study aims  
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C.6.3.1: Aim 1: Depression and Anxiety after an Acute Coronary Syndrome: a 
Bivariate Mixed Model Approach 
         We compared unconditional means, unconditional growth models (fixed time), and 
conditional models (fixed time, experimental status, and time by status interaction) to 
examine the variance parameters of the regression models. Goodness of fit was assessed 
with Akaike’s information criterion. We assumed a linear trend model that provided a 
better fit than curvilinear models. A bivariate mixed model with an unstructured 
covariance matrix was employed to estimate correlation coefficients for depression and 
anxiety over time 58. Bivariate linear mixed models are useful when analyzing 
longitudinal data of two or more highly associated variables. Comparison of the 
correlation coefficients obtained was conducted by calculating z-statistics according to 
the method of Fisher 58.  We used SAS 9.1.3 software (PROC MIXED) to fit all models 
58.  
C.6.3.2: Aim 2: Identifying Classes of Response to Treatment of Depression, Anxiety 
and Function in Patients After an Acute Coronary Syndrome:  
 Latent transition analysis (LTA) was used to identify subgroups of patients with similar 
patterns of depression, anxiety, and function, and to describe changes over time in these 
patients groups.  Latent transition models describe change over time in outcomes that are 
not directly observed. That is, the outcomes in latent transition models are inferred based 
on information from a set of observed variables 54-57. The latent transition model 
combines cross-sectional measurement of categorical latent variables and the longitudinal 
description of change in categories of the latent variable over time. One important 
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advantage of these models is that they allow investigators to examine the impact of the 
intervention, CBT in this case, on change in depression, anxiety, and functional 
symptoms simultaneously.   
          Selection of the optimal model that considered both goodness of fit and parsimony 
was based on various statistical fit indices. Statistical indices reported in this 
investigation included:  the Akaike information criterion (AIC), Bayesian information 
criterion (BIC) and G2. Model selection was also based on: the log-likelihood ratio, and 
the number of estimated parameters in the model 54-57. Lower values for the BIC, AIC 
and G2 indicate better model fit 54-57.  Latent Transition Analysis estimates the propor tion 
of patients in each class at each time point, and the probability of moving from one class 
to another, conditioned on prior membership status 54-57. 
         Latent Transition Analysis involves four different types of parameters: the gamma 
parameters, which are estimates of the proportion of the population in each latent class or 
subgroup 57. The delta parameters which are estimates of the proportion of the population 
in each latent status at each occasion of measurement 57. The tau parameters which refer 
to the conditional probability of transitioning from one latent class to another, and lastly 
the rho parameters, which represent measurement error, are estimates of a particular item 
response conditional on latent class and latent class membership 57. 
C.6.3.3: Aim 3:  Profiling Symptoms of Depression and Anxiety in Acute Coronary 
Syndrome Patients Using Latent Class and Latent Transition Analysis:  Latent class 
analysis (LCA) and latent transition analysis (LTA) were used to identify subgroups of 
patients with similar patterns of depression and anxiety symptoms, and to describe 
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change over time in subgroup membership. Latent class analysis identifies a set of 
mutually exclusive and exhaustive latent classes characterized by similar patterns of 
responses to manifest items 54-57. Latent transition analysis is a longitudinal extension of 
latent class analysis that additionally models change over time in class membership 54-57. 
Latent class analysis and latent transition analys is are measurement models meaning that 
they separate out measurement error from other aspects of the model. Latent class 
analysis estimates the probabilities of responding to items in different ways given class 
membership, as well as the distribution of the classes. Latent transition analysis 
additionally estimates the probabilities of transitioning between classes over time. The 14 
items of the HADS were included in the models to measure depression and anxiety 
symptom profile. The 14 items were re-coded so one represented never or rarely ever 
experiencing the symptom and two represented experiencing the symptom sometimes or 
most of the time 
C.7: Study limitations 
      Several limitations of this study must be considered in interpreting my study findings. 
• Generalizability: based on subject inclusion criteria, and limitations of the subject 
selection criteria based on baseline rates of anxiety and depression (scores from 7 
to 15 in the HADS) 
• Generalizability to sites other than urban, tertiary care centers and possible      
bias because of exclusion of individuals receiving mental health treatment in 
      the period before the index hospitalization. 
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• Generalizability: minority and ethnic patients were under-represented (88% white, 
6% black and 6% missing) 
• Power: sample size=79 , but latent growth model based on number of 
observations  (N=268) 
• The study relied upon patient self-reports that needs to be validated with more 
objective outcome measures to prevent misclassification.  
• Patient’s dexterity and visual ability to comply with intervention (completing the 
HADS over the phone) 
         Despite these limitations, this study will provide several useful insights. This study 
will longitudinally assess patterns and predictors of depression and anxiety in the 6 
months following an ACS event. This information will allow clinicians to better diagnose 
and treat anxiety and depression. 
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Background: Depression and anxiety inhibit recovery, and have a negative impact on 
social functioning in pa tients after an acute coronary syndrome (ACS). Few studies have, 
however examined pa tterns of change in anxiety and depression after an ACS 
Objectives: Determine trajectories of depression and anxiety after an ACS, to examine 
the effect of cognitive behavioral therapy (CBT) on depression and anxiety, and examine 
if anxiety and depression symptoms change at the same rate with CBT treatment as 
indicated by joint modeling o f these two psychiatric disorders.    
Participants/Measurements: A total of 100 patients with an ACS with scores on the 
Hospital and Anxiety Depression Scale (HADS) indicating mild to severe depression 
and/or anxiety at 1 month post-hospital discharge were enrolled in a randomized trial of 
CBT and were followed for changes in anxiety and depression at 2, 3, and 6 months post-
baseline.  
Main Results: The average age of study pa tients was 60 years and 30%  were women. 
Patients in the intervention group had a 20% of improvement in their HADS scores at the 
end of the study. Patterns of changes from the joint modeling o f both psychiatric 
disorders were similar in the intervention and control groups; the correlation, however, 
was significantly higher in the treatment group at all follow-up points.  
Conclusions: Our results indicate that depression and anxiety are highly correlated and 
persistent in patients with an ACS both at baseline and over time. The intervention does 
not appear to uncouple the association between anxiety and depression, suggesting that 
CBT has comparable effects on both psychiatric disorders.   
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Introduction 
         Acute coronary syndrome (ACS), including acute myocardial infarction and 
unstable angina, represents common cardiac diseases in the majority of industrialized 
countries.  Acute coronary syndrome is a leading cause of death, and disability, and also 
significantly impacts patient’s quality of life and functional status [1].  In the United 
States, ACS affects approximately 16 million people [2-4].  Patients with an ACS, like 
other chronically, medically ill individuals, experience considerable stress in adjusting to 
living with their illness.  Thus, it is not surprising that depression and anxiety are more 
prevalent in chronically physically ill individuals, including those with an ACS, than in 
the general population [2-3, 5 -7].  Moreover, depression and anxiety tend to occur 
together. Recent findings suggest that approximately 60% of depressed patients may have 
concomitant anxiety [8].  Patients with an ACS and symptoms of depression and anxiety 
not only show higher long-term morbidity and mortality but also report decreased 
compliance with medication , slower return to work, a nd worse quality of life than 
patients without symptoms of those psychiatric disorders [9-10]. Despite the high 
prevalence of anxiety and depression in patients with an ACS, and their role as predictors 
of higher morbidity and mortality, both of these common yet serious disorders are often 
under-diagnosed and under-treated in pr imary care settings [5, 8, 11].  Because of its 
public health importance, depression in cardiac patients has been the subject of quality 
improvement research including intensive and large scale mortality trials aimed at 
reducing risk of death through treatment of depression [2-4].  Researchers found that 
CBT was effective for reduction of depressive symptoms, but unfortunately there was not 
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much information reported about the effect of CBT on the co-occurrence of depression 
and anxiety and their pattern of change over time [12]. 
         The objectives of this study were to determine the trajectories of depression and 
anxiety after an ACS, to examine the joint distribution of treatment effects of cognitive 
behavioral therapy (CBT) on depression and anxiety, and to determine if bo th psychiatric 
disorders change at the same rate accompanying CBT treatment using novel bivariate 
mixed model methods. Data from a previously reported randomized trial of CBT 
treatment of patients with an ACS were utilized to examine our study hypo theses [13].    
Design and Methods: 
         The study group consisted of 100 patients hospitalized with an ACS in two 
coronary care units at a university hospital in Boston, MA, between September, 2001 and 
August, 2003 [13-15].  Patients were 35 years and older at the time of trial entry and had 
symptoms corresponding to mild to moderate levels of depression and/or anxiety as 
indicated by a score of seven or higher on either of the subscales of the Hospital Anxiety 
Depression Scale (HADS).  None of the study pa tients had received mental health care in 
the prior three months, used a psychoactive drug during the past year; or were diagnosed 
with substance abuse during the past year.  Potentially eligible patients were identified by 
a research nurse through the review of hospital records and hospital census information. 
The diagnosis codes used to identify patients for this study included acute myocardial 
infarction, unstable angina, and ischemic heart disease. Patients were screened at 
approximately one month after hospital discharge for an ACS and those meeting the 
predefined study inclusion criteria were randomly assigned to treatment or control status. 
  
33 
 
         Patient recruitment began during the index hospitalization. Once patients consented 
to trial enrollment, the study coordinator administered the 14- item HADS by phone to 
assess the symptoms of anxiety and depression. Subjects with scores between 7 and 15 on 
either the anxiety or depression scale were enrolled into the trial and randomized into the 
intervention or usual care comparison groups.         
          The trial intervention consisted of a series of CBT sessions that helped patients 
identify and manage the challenges of living with a chronic condition [13].  Patients in 
the control group received information on coping with cardiac disease.  Baseline survey 
assessments (within 30 da ys of hospital discharge) included the Primary Care Evaluation 
of Mental Disorders (PRIME-MD) and the Hospital Anxiety and Depression Scale 
(HADS), our primary outcome measure [13].  The HADS was re-administered at two, 
three, and six months after trial enrollment [13].   The study protocol was reviewed and 
approved by the institutional review board of the participating hospital.   
         The trial intervention consisted of CBT that helped patients identify and manage the 
challenges of living with chronic cardiac disease [13].  This intervention was goa l-
oriented, time- limited, and issue-focused. It was based on other telephone interventions 
targeted to treat depression by modulating the risk of depression, anxiety, and functional 
decrements through improved adjustment to illness and has been well-described 
elsewhere [13].  Individual sessions lasted for approximately 30 minutes and were 
conducted by doctoral- level clinicians. Patients were expected to complete six sessions, 
but were allowed to participate in as few as three sessions if the therapist and patient 
Intervention 
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agreed that all issues set forth during treatment were reviewed and that treatment goals 
were reached. Patients randomly assigned to the control group received a booklet on 
coping with cardiac illness, typical of those given to pa tients with an ACS at the time of 
hospital discharge, and were instructed to contact their primary care physician if they 
experienced any warning signs of depression.  
         Data were collected at the time of baseline enrollment for the HADS, functional 
status at home and at work, and a self-rated health and anger questionnaire using 
interactive voice recognition (IVR) system. Patients completed only the HADS at the 
time of the two, three, and six month study follow-up visits. An aggressive follow-up 
system consisting of reminder postcards, telephone call reminders, and re-mailing o f 
questionnaires was undertaken to enhance survey response rates. 
Data Collection Protocols  
 
         The HADS contains seven questions related to depression and seven related to 
anxiety. Each scale is scored from 0 to 21; scores between 4 and 7 represent subclinical 
depression whereas patients who scored 8 or higher were classified as being 
‘‘depressed’’. The same criteria and scores were used for diagnosing anxiety.  It is 
important to highlight that previous research into the dimensional structure of the HADS 
reported evidence for a two-factor solution that corresponded almost exactly with the 
anxiety and depression subscale [16]. A key element of using the HADS is that this scale 
focuses on cognitive rather than somatic constructs, which minimizes the likelihood that 
somatic symptoms of an ACS will be attributed to depression. 
Assessment Instrument 
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         Descriptive analyses on baseline patient characteristics were performed; t-tests and 
chi-square tests, as appropriate, were used to examine possible differences in baseline 
categorical and continuous variables between patients randomly assigned to the 
intervention and control groups.  
Data Analysis 
We compared unconditional means, unconditional growth models (fixed time), 
and conditional models (fixed time, experimental status, and time by status interaction) to 
examine the variance parameters of the regression models. Goodness of fit was assessed 
with Akaike’s information criterion. We assumed a linear trend model that provided a 
better fit than curvilinear models. A bivariate mixed model with an unstructured 
covariance matrix was employed to estimate correlation coefficients for depression and 
anxiety over time [17]. Comparison of the cor relation coefficients obtained was 
conducted by calculating z-statistics according to the method of Fisher [17].  We used 
SAS 9.1.3 software (PROC MIXED) to fit all models [18, 19]. 
Results: 
         Between September, 2001 and August, 2003, a total of 706 participants were 
screened for potential trial enrollment. Of these, 38% were excluded based on the trial 
eligibility criteria, and an add itional 34% declined trial participation. Of the 280 patients 
administered the HADS, 36% met the inclusion criterion by scoring between 7 and 15 on 
either or both measures. Of these patients, 47 were randomized to control status and 53 to 
the intervention group. Twenty eight percent of study patients dropped out of the study 
from the control group, which included one death. Fifteen percent of the patients from the 
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treatment group dropped out of the study. Dropouts were comparable with participating 
trial patients on various baseline characteristics as determined by standard t-tests and chi-
square tests statistics. 
         The final cohort consisted of 79 patients (34 in the control and 45 in the 
intervention group). Of the 79 patients with an ACS, 37 (47%) met the study inclusion 
criteria for both anxiety and depression; of the remaining 42 patients, 31 met the 
depression, but not anxiety criterion, and 11 met the anxiety criterion solely.  
         At the time of randomization, the two groups were well balanced with a 
predominance of white, older male patients in both groups.  Average depression and 
anxiety scores were slightly higher for the treatment group at baseline (Table 1). In 
examining possible differences in average depression and anxiety scores at the different 
study follow-up points, similar trajectories were observed in the treatment and control 
groups for bo th psychiatric disorders. There was a significant decline in the mean 
depression and anxiety scores from baseline that was significantly greater in the 
intervention group (Figures 1A and B).  
         Almost half of the patients assigned to the CBT group met the criteria for 
depression and anxiety at the time of trial enrollment. The prevalence for both psychiatric 
disorders was lower in the control group at the same time of assessment: 16% of these 
patients satisfied the criteria for anxiety and depression respectively (Table 2). The two 
month prevalence rates of depression and anxiety decreased by nearly one half in the 
treatment group but did not change in the control group. Lastly, the three and s ix month 
prevalence for both psychiatric disorders did not change, and approximately one quarter 
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of the patients met the criteria for depression and anxiety in the treatment and control 
groups. 
         Regression results showed a significant decrease in depression scores from baseline 
in the intervention group (Table 3). The fina l mean depression score was 1.96 units lower 
in the treatment group than in controls at six months. Similar results were observed for 
the analysis of intervention effects on anxiety scores. Regression results indicated a 
significant decline in the linear trend and a lower score of 2.2 units in the intervention 
group a t six months (Table 3).   
         Lastly, the correlations coefficients and standard errors for the bivariate model were 
estimated to examine the extent of the correlation between depression and anxiety at 
baseline, two, three and six months and determine how these scores change in relation to 
CBT (Table 4). The results from the bivariate random effects model showed a strong 
correlation between depression and anxiety in the treatment and control groups. The 
correlations between anxiety and depression scores followed a similar trajectory in the 
intervention and control group over time (Figure 2), but the estimated cor relation 
coefficients were higher in the treatment group at the different time points (Table 4). 
These higher correlation coefficients may be related to the differential effects of the 
intervention in the treatment group.   
Discussion:   
         The results of this study indicate that symptoms of depression and anxiety are 
common and persistent in patients with an ACS at baseline and during 6 months of 
follow-up as documented in other investigations [11, 12, 14]. In the treatment group the 
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prevalence of anxiety and depression decreased by one-third after two or three months of 
follow-up, but some symptoms of depression and anxiety persisted even after one year. 
Both psychiatric disorders are also highly correlated as has been previously observed. But 
unlike any other studies of which we are aware, we were able to model measures of 
depression and anxiety symptoms simultaneously in a longitudinal, patient- level research 
design.   We used this approach to examine whether CBT treatment “uncoupled” the well 
documented co-occurrence of depression and anxiety relative to control patients. 
Similarly, this approach enabled us to examine whether evidence based CBT treatment of 
depression in patients with an ACS provided any additional “pay-off” on improving 
anxiety symptoms.  This information is valuable since depression and anxiety may be 
independent risk factors for morbidity, mortality, diminished quality of life and ot her 
outcomes in patients with an ACS [9-10].    
          Study results showed a strong correlation between depression and anxiety that 
persisted over time in both the treatment and control groups, although the correlation 
appears to be slightly lower but with a similar pattern in the control group. Patients who 
received CBT showed a significant decrease in the mean scores for depression and 
anxiety and this reduction in scores plus the high correlation for both psychiatric 
disorders may be explained by the administration of CBT. The intervention does not 
appear to uncouple this correlation in the experimental group, suggesting that the 
intervention has comparable effects on both depression and anxiety.  These findings then 
suggest that patients with an ACS and symptoms of depression and anxiety may benefit 
Correlation of Anxiety and Depression in Patients with an ACS who Received CBT 
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from interventions, such as CBT, that target both disorders at the same time. It is also 
important to emphasize that not only it is recommended that the intervention should 
address both psychiatric disorders but also the statistical method implemented should 
allow the researchers to measure the effect of the intervention through joint modeling to 
obtain a more accurate result.  
         Several prior studies have also reported high levels of co-existing depression and 
anxiety in patients with an ACS over time. In a prospective study in the U.K., 288 
hospitalized patients with a myocardial infarction (MI) were assessed for symptoms of 
depression and anxiety using the Beck Depression Inventory (BDI) and the State–Trait 
Anxiety Inventory (STAI) between 2–15 days after the occurrence of a MI [20]. These 
patients were re-assessed for depression and anxiety at 4 and 12 months.  During the 
period of hospitalization, 31% and 26% of patients met the criteria for depression and 
anxiety, respectively. The 4 and 12 month prevalence rates were 38 % and 37% for 
depressive symptoms, and 42% and 40% for symptoms of anxiety, respectively [20]. 
Depression and anxiety were highly associated, with 51% of patients experiencing 
significant levels of depressive and anxious symptoms at baseline. More than half the 
patients with complete BDI and STAI data experienced either elevated symptoms of 
anxiety or depression throughout the year following a MI [20].  
Prevalence of depression and anxiety in patients with an ACS  
         In another British prospective study slightly different results were found. The 
researchers collected demographic and cardiological data for all patients (n=347) from a 
defined geographical area in the U.K who had had a MI. The mean age of the patients 
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was 60 years and 70% were males [9]. The patients completed the HADS and the 36- item 
Medical Outcomes Study shor t form at baseline, 3 months and 1 year later [9]. Fifteen 
percent of patients were scored as having symptoms of anxiety or depression. There was 
an improvement at 3 months, but there was little overall or individual change after that 
time in symptoms of both psychiatric disorders [9]. An important difference between the 
results in both British studies and our find ings  is that the researchers in the U.K. studies 
examined anxiety and depression as separate psychiatric disorders and did evaluate the 
joint distribution of these two psychiatric disorders nor did they assess the efficacy of any 
type of intervention applied to these two psychiatric disorders.        
Study strengths and limitations
         Further longitudinal studies would benefit from longer follow-up time, expansion of 
site numbers, and a larger sample. Patients with very severe depression/ anxiety and also 
patients who had received mental health care in the prior three months or had a diagnosis 
of substance abuse during t he past year were excluded from this study. Thus, our find ings 
may not apply to these high risk individuals.  Data gathered on depression and anxiety in 
our study relied upon self-report.  
  
Joint modeling o f related outcomes such as those studied in this investigation 
promise to be very useful in determining the change over time of one outcome as it is 
highly related to another [19]. These models are of particular importance in 
understanding multi-dimensional profiles of psychopa thology in pa tients with mental 
disorders who typically demonstrate multiple maladaptive behaviors, a variety of 
Conclusions  
  
41 
 
symptoms and decrements in various domains of function all of which are typically 
correlated.  A better understanding o f the relative contributions of these various but inter-
dependent phenomena in patients’ symptoms, function and quality of life could inform 
appropriate targets for interventions to achieve desired benefits. Even though the 
implementation of these models could be broadly used and helpful in psychiatry and 
other medical specialties, they still rarely used.   Although this study used bivariate mixed 
effects models, the conceptual and operational approach to modeling more than two 
outcomes is the same for higher number of outcomes.  
         In summary, our results indicate that depression and anxiety are highly correlated in 
patients with an ACS both at baseline and across six months of follow up. The 
intervention does not appear to uncouple the correlation between these highly comorbid 
psychiatric disorders in the experimental group, suggesting that the intervention has 
comparable effects on bo th depression and anxiety. Future research needs to investigate 
the role of anxiety and depression as a joint phenomenon in order to more precisely 
clarify the effects of these psychiatric disorders on mortality, morbidity and quality of life 
in patients after an ACS. Additional studies are also needed to compare the effectiveness 
and cost-effectiveness of CBT and o ther interventions targeting bot h psychiatric disorders 
jointly.  
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Table 2.1: Characteristics of the study sample according to treatment status 
VARIABLE TREATMENT (N=45) CONTROL (N=34) 
Age (mean, years) 59.9 60.7 
Female (%) 31.1 35.3 
White (%) 88.9 88.1 
History of Ischemic Heart Disease (%) 40.0 47.8 
Length of hospital stay (mean, days) 3.6 3.1  
Major Depression History (%) 37.8 29.4 
HADS Depression Scores (mean) 8.5  6.5  
HADS Anxiety Scores (mean) 8.1  7.1  
 
 
 
 
Figures 2.1-A: HADS Depression scores over time 
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Figures2. 1-B: HADS Anxiety scores over time 
 
 
 
 
Table 2.2: Prevalence of depression and anxiety according to treatment status 
 
 Treatment (n=45) Control (n=34) 
Depression Anxiety Depression Anxiety 
Baseline 47% 46% 15% 25% 
2 months 24% 29% 16% 27% 
3 months 20% 21% 23% 27% 
6 months 19% 20% 15% 22% 
 
 
 
 
 
Table 2.3: Fixed and random effects estimates for the effects of treatment on anxiety 
and depression 
 Depression  Estimate (SE) Anxiety Estimate (SE) 
Intercept 7.8 (0.7)* 8.93 (0.66)* 
Time -0.08 (0.13) -0.01 (0.14) 
Treatment  -1.96 (0.05) -2.2 (0.02) 
Time*Treatment -0.38 (0.17)* -0.39 (0.18)* 
* P-value <0.05 
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Figure2. 2:  Estimated correlation coefficients for depression and anxiety over time 
 
Table 2.4: Correlation estimates, standard errors and confidence intervals by time of 
assessment 
 
time Correlation estimate (SE) (CI) Z-statistic 
Treatment N=45 Control N=34 
Baseline 0.37  (0.06)   (0.25-0.49) 0.08  (0.22)  (-0.36-0.52) 1.29  
2 months 0.88  (0.13)   (0.62-1.14) 0.41  (0.42)  (-0.43-1.25) 3.90 * 
3 months 0.69  (0.11)   (0.47-0.91) 0.24  (0.28)  (-0.32-0.8) 2.50 * 
6 months 0.64  (0.1)     (0.44-0.84) 0.29  (0.23)  (-0.17-0.75) 1.92  
* P-value <0.05  
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Background: Depression and anxiety are associated with higher mortality rates and 
diminished quality of life in patients with an acute coronary syndrome (ACS). While 
these psychiatric disorders are prevalent in patients with an ACS, they are usually 
undertreated. 
Objectives: The objectives of this study were to (1) identify symptomatology profiles of 
depression, anxiety, and functional impairment among patients with an ACS, (2) describe 
change over time in symptomatology profile, and (3) determine if patients receiving 
cognitive behavioral therapy (CBT) showed signs of remission in depression, anxiety and 
impaired function earlier than patients that received usual care. In add ition, the 
association between symptomatology profile and age, gender and lengt h of stay in the 
hospital was examined.    
Methods: A total of 100 patients with an ACS and mild to severe depression and/or 
anxiety at one month post-hospital discharge were enrolled in a randomized trial of CBT. 
These patients were followed for change in anxiety and depression at two, three, and six 
months post-baseline enrollment. Latent transition analysis was used to identify patients’ 
symptomatology profiles and to describe changes in those profiles over time.   
Results: The average age of study patients was 60 years and 30%  were women.  The 
latent transition model specifying a three-class solution was selected to identify and 
describe symptomatology profiles. One class was characterized by patients with both 
psychiatric disorders and impaired function, the second by patients with psychiatric 
disorders but normal function, and the third by patients with anxiety but without 
depression, and having normal function. As compared to a control group receiving usual 
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care, patients who received CBT reported higher rates of symptomatology remission (i.e. 
transition from latent classes I and II to latent class III) between baseline and month-two 
follow-up. There was moderate improvement in depression, anxiety and function for 
control patients in latent classes I and II at the three and six-month follow ups, but this 
improvement was less evident than in the experimental group.  Women showed a better 
response to C BT than men. 
Conclusions: Examining transitions between symptomatology profiles provides a detailed 
look at change over time that is difficult to obtain in more traditional data analysis. This 
statistical approach thus clarifies periods during which an intervention is most likely to be 
effective.  
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Depression and anxiety are highly prevalent disorders in patients after an acute coronary 
syndrome (ACS) 1-7.   Depression and anxiety appear to inhibit recovery, and have a 
negative impact on social functioning and capacity to perform activities of daily living in 
patients who develop an ACS 3, 4, 6, 8-13.  Even though these conditions are prevalent in 
patients with an ACS, and associated with poorer quality of life, these disorders are not 
fully recognized and adequately treated in clinical settings.  
         In the current study, latent transition analysis is used to identify and describe 
profiles of symptoms that are defined by different patterns of depression, anxiety and 
function. Second, we examine whether treatment predicts change in symptomatology 
profile over time. Lastly, we determine if age, gender and length of stay in the hospital 
predict remission of symptoms. Both psychiatric disorders and impaired function are 
considered together here, because it has been shown that these negative outcomes are 
highly prevalent in patients with an ACS, and highly correlated 12.  Latent transition 
analysis (LTA) provides a different and original approach to determining symptom 
profiles of depression, anxiety and function in patients after an ACS 14-16. In LTA, the 
unit of analysis is an individual’s profile of symptoms. Latent transition analysis has 
several strengths, it combines the cross-sectional measurement and the longitudinal 
description of change in categor ies of the latent variable over time and, it has great 
flexibility in describing progression, stability, and remission of symptoms14-16.  
          Data from a randomized controlled trial of patients treated for an ACS at two 
coronary care units were utilized to examine outcomes over a six-month follow-up period 
after hospitalization 12, 13.  
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Design and Methods: 
         The study sample consisted o f 100 patients hospitalized with an ACS in two 
coronary care units at a university hospital in Boston, MA, between September, 2001 and 
August, 2003 12, 13.  Patients were 35 years and older at the time of trial entry and had 
symptoms corresponding to mild to moderate levels of depression and/or anxiety as 
indicated by a score of seven or higher on either of the subscales of the Hospital Anxiety 
Depression Scale (HADS).  None of the study pa tients had received mental health care in 
the prior three months, used a psychoactive drug during the past year, or had be en 
diagnosed with substance abuse during the past year.  Potentially eligible patients were 
identified by a research nurse through the review of hospital records and hospital census 
information. The diagnosis codes used to identify patients for this study included acute 
myocardial infarction, unstable angina, and ischemic heart disease. Patients were 
screened a t approximately one month after hospital discharge for an ACS, and those 
meeting the predefined study inclusion criteria were randomly assigned to the 
intervention (i.e. CBT) or control status (i.e. usual care) 12, 13. 
         Patient recruitment began during the index hospitalization. Once patients consented 
to trial enrollment, the study coordinator administered the 14- item HADS by phone to 
assess symptoms of anxiety and depression. Subjects with scores between seven and 15 
on either the anxiety or depression scale were enrolled into the trial and randomized into 
the intervention or usua l care comparison groups12, 13.         
          The trial intervention consisted of a series of CBT sessions that helped patients 
identify and manage the challenges of living with a chronic condition 12.  Patients in the 
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control group received information on coping with cardiac disease.  Baseline survey 
assessments (within 30 da ys of hospital discharge) included the Primary Care Evaluation 
of Mental Disorders (PRIME-MD), the Work and Social Adjustment Scale (WSAS) and 
the Hospital Anxiety and Depression Scale (HADS), our primary outcome measure 12.  
The HADS and the WSAS were re-administered at two, three, and six months after trial 
enrollment for purposes of assessing change in depression, anxiety and function at 
home12.   The study protocol was reviewed and approved by the institutional review 
board of the participating hospital.   
         The trial intervention consisted o f CBT that helped pa tients identify and manage the 
challenges of living with chronic cardiac disease 12.  It has been described in details 
previously and will only be briefly summarized here. This intervention was goal-oriented, 
time- limited, and issue-focused. It was based on other telephone interventions targeted to 
treat depression by modulating the risk of depression, anxiety, and functional decrements 
through improved adjustment to illness 12.  Individual sessions lasted for approximately 
30 minutes and were conducted by doctoral- level clinicians. Patients were expected to 
complete six sessions, but were allowed to participate in as few as three sessions if the 
therapist and pa tient agreed that all issues set forth during treatment were reviewed and 
that treatment goals were reached. Patients randomly assigned to the control group 
received a booklet on coping with cardiac illness, typical of those given to patients with 
an ACS at the time of hospital discharge, and were instructed to contact their primary 
care physician if they experienced signs of depression.  
Intervention 
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         Data were collected at the time of baseline enrollment for the HADS, the WSAS, 
and a self-rated health and anger questionnaire using interactive voice recognition (IVR). 
Patients completed the HADS and the WSAS at the time of the two, three, and six month 
study follow-up visits. An aggressive follow-up system consisting of reminder postcards, 
telephone call reminders, and re-mailing o f questionnaires was utilized to enhance survey 
response rates.  
Data Collection Protocols  
         The HADS contains seven questions to assess depression and seven to assess 
anxiety. Each scale is scored from 0 to 21; scores between four and seven represent 
subclinical depression whereas patients who scored eight or higher were classified as 
being ‘‘depressed’’. The same criteria and scores were used for diagnosing anxiety. One 
important advantage of using the HADS is that this scale focuses on cognitive rather than 
somatic constructs, which minimizes the likelihood t hat somatic symptoms of ACS will 
be attributed to depression. 
Assessment Instrument 
         The work and social adjustment scale (WSAS) was utilized to assess function in 
this group o f patients.  The WSAS is a validated measure of self-reported functional 
impairment at work, home management, social and private leisure, and personal 
relationships. Each of the five domains is scored from no impairment (zero) to severe 
impairment (eight), with a score of three to five suggestive of moderate impairment 12, 13. 
         Depression, anxiety, and function scores were dichotomized for purposes of 
analysis. Patients who scored below eight on the HADS in any of the two subscales were 
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classified as non-depressed/non-anxious; patients who scored from eight to fifteen were 
classified as being depressed or anxious. Patients who scored above 15 in the WSAS 
were classified as having moderate to severe impairment in function at home and work, 
and those that scored below 15 were classified as being without functional impairment 12.   
         Descriptive analyses of patient baseline characteristics were performed; t-tests and 
chi-square tests, as appropriate, were used to examine possible differences in baseline 
variables between patients randomly assigned to the intervention and control groups.  
Data Analysis 
        Latent transition analysis (LTA) was used to identify subgroups of patients with 
similar patterns of depression, anxiety, and function, and to describe changes over time. 
Latent transition models describe change over time in outcomes that are not directly 
observed 14-15. That is, the outcomes in latent transition models are inferred based on 
information from a set of observed variables 16. The latent transition model combines 
cross-sectional measurement of categorical latent variables and the longitudinal 
description of change in categories of the latent variable over time. One important 
advantage of these models is that they allow investigators to examine the impact of the 
intervention, in this case CBT, on change in depression, anxiety, and func tion symptoms 
simultaneously.   
          Selection of the optimal model that considered both goodness of fit and parsimony 
was based on various statistical fit indices. Statistical indices reported here include :  the 
Akaike information criterion (AIC), Bayesian information criterion (BIC) and G2.Model 
selection was also based on: the log- likelihood, and the number of estimated parameters 
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in the mod el 14-18. Lower values for the BIC, AIC and G2 indicate better model fit 16-18.  
Latent Transition Analysis estimates the proportion of patients in each class at each time 
point, and the probability of moving from one class to another, conditioned on prior 
membership status 16-18. 
         Latent Transition Analysis involves four different types of parameters: the gamma 
parameters, which are estimates of the proportion of the population in each latent class or 
subgroup 19. The delta parameters which are estimates of the proportion of the population 
in each latent status at each occasion of measurement 19. The tau parameters which refer 
to the conditional probability of transitioning from one latent class to another, and lastly 
the rho parameters, which represent measurement error, are estimates of a particular item 
response conditional on latent class and latent class membership 19. 
Results: 
         At the time of randomization, the control and intervention groups were well 
ba lanced with respect to a variety of patient characteristics (Table 1); both groups were 
predominantly comprised of white, older males.  Average depression and anxiety scores 
were slightly higher for the intervention group a t baseline but the differences were not 
statistically significant.      
         Latent transition models with two, three, and four latent classes were fit and 
compared (Table 2). Model identification was checked using 100 sets of random starting 
values.  As shown in Table 2, the three class model had the lowest AIC (499.58), but the 
two class model had the lowest BIC (613.78). An examination of the two and three class 
Symptomatology Profiles 
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models revealed the emergence of a latent class characterized by psychiatric disorders but 
high function in the three class model. Because of the potentially important differences 
between this class and a class with psychiatric disorders and impaired function, which 
appeared in both the two and three class models, the three class model was selected as the 
best at balancing model fit and parsimony in its description of the data. 
       
        Item-response probabilities are one set of parameters estimated in latent transition 
models and they serve two roles. F irst, they de fine the latent classes. In addition, the 
item-response probabilities reflect measurement precision. Reliable measurement of the 
latent class variable is reflected in estimates that are close to zero or one. For example, 
probabilities that are close to zero for having depression and impaired function for 
members of  latent class III, indicates that membership in this latent class (almost) 
completely determines the response to these manifest items. An estimate that approaches 
0.5 indicates an item response that is poorly determined by latent class membership 16-17.  
Profiles of Depression, Anxiety and F unction in the Study Sample  
         The estimated item-response probabilities for having anxiety, depression and 
impaired function for the 3-class model are reported in Table 3. The first class was 
labeled “patients with psychiatric disorders and impaired function”; the second class was 
labeled “patients with psychiatric disorders and normal function”; and the third class was 
labeled “patients with moderate anxiety and normal function, but without depression” 
(Table 3). In latent class I, patients had high probabilities of endorsing each of the three 
indicators, meaning that patients in latent status I were depressed, anxious and had severe 
impairment in their function at home; in addition the latent class was well-defined by the 
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observed psychiatric disorders and function. Patients in latent class II were characterized 
by high depression and anxiety scores, but they did not have any impairment in function 
at home. Finally, patients in latent class III were characterized as being without 
depression or having any impairment in their function at home; they did, however, 
exhibit moderate symptoms of anxiety.  
         Latent class membership probabilities are a second set of parameters estimated in 
latent transition models and they are the expected percentage of patients which each 
symptomatology profile at each time point of observation 18-19. The estimated latent class 
membership probabilities over time are reported in Figures 1 A and B. Patients in the 
treatment group showed an important decline in the probability of belonging to latent 
class I (psychiatric disorders and impaired function) over time. In other words, the 
probabilities of membership in latent classes II and III increased over time, meaning that 
patients in the treatment group repor ted reduced impairment of function over time. The 
control group patients also showed a similar decreasing trend in membership in latent 
class I over time, but his decrease was less pronounced than in the treatment group.  
         
          Transition probabilities are a third and final set of parameters estimated in latent 
transition models and they describe change over time in class membership. The estimated 
transition probabilities are reported in Table 4. Each row in Table 4 is row conditional, 
such that each row sums to one. These probabilities are interpreted as the probability of 
time t+1 latent class membership (columns), conditional on latent class membership at 
time t (rows). In the control group, most of the patients remained in the same class 
Transitions between Latent Classes 
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between any two times, with no remission or reappearance of symptoms over time. For 
those in the intervention group, a lmost 30% of the patients with depression, anxiety and 
impairment in their function at baseline showed remission of their symptoms for both 
psychiatric disorders and function at month two. Among those in latent class II, more 
than 60% transitioned to latent class III at the time of the two-month follow-up, showing 
an improvement in their symptoms. There was moderate improvement in depression, 
anxiety and function for patients in latent classes I and II at the three and six-month 
follow ups, but this improvement was less significant than had been previously observed. 
In summary, the effects of the intervention were more evident in the transitions from 
baseline to two-month follow than in any other follow-up period for all three indicators of 
the psychiatric disorders and function.     
         In order to consider the effects of different covariates in predicting remission of 
symptoms of depression, anxiety and impaired function, posterior probabilities were 
calculated and used to assign patients to a latent class at each point assessed. Although it 
is possible to incorporate covariates directly into the latent transition model 18, due to the 
small sample size of the current study, this method was preferred. The quality of latent 
class assignment was evaluated by examining the average posterior probability of 
patients assigned to a class at each time point.  The average posterior probabilities were 
high for each latent class at each time point ranging from 0.75 to 0.99. These results 
indicated a high likelihood of each patient belonging in the class to which he/she was 
assigned.  
Predictors of Response to the Intervention 
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         Generalized estimating equations were then used to determine if the covariates age, 
gender and lengt h of stay in the hospital were predictive of the remission of symptoms of 
both psychiatric disorders and impaired function.  The covariates were included one at a 
time and then combined in the generalized estimating equation models. Gender was the 
only covariate found to be a statistically significant predictor of remission of symptoms 
(p-value=0.042). Women showed a significant response to C BT, such that women in the 
intervention group were more like ly than men to transition from latent class I (depression, 
anxiety and impaired function) and II (depression, anxiety and normal function)  to latent 
class III (moderate anxiety).  
Discussion:  
         The first objective of this study was to identify different symptomatology profiles 
of depression, anxiety and function in patients with an ACS over time. Our results 
showed that patients with an ACS could be classified into three different latent classes or 
profiles. The first class was labeled “Patients with the psychiatric disorders and impaired 
function”; the second class was labeled “Patients with the psychiatric disorders but 
normal function” and the third class was labeled “Patients with moderate anxiety, no 
depression and normal function”. The results showed that 80% of patients who were 
members of latent class I reported depression, 94% reported anxiety, and 84% reported 
impaired function. Comparatively, in latent class II, 100% of patients reported 
depression, 75% reported anxiety, and none of them reported any symptoms of impaired 
function. Lastly, 5% of patients who were members of latent class III reported symptoms 
of depression, 37% reported symptoms of anxiety, and less than 4% reported signs of 
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impaired function. In summary, our findings showed that depression and anxiety were 
highly prevalent disorders in latent classes I and II in this group of patients. The clinical 
implication of these results is that it is important to assess and consider both disorders in 
order to be tter diagnose and treat patients with an ACS. 
         The second objective of this study was to examine change over time in the profiles 
of depression, anxiety and function among patients with an ACS who were randomized to 
CBT and usual care treatment. Patients in our study had a high likelihood of belonging to 
the latent class characterized by depression, anxiety and impaired function at baseline 
(almost 70% in the control and more than 50% in the treatment group). This probability 
decreased over time in both the treatment and control group, but decreased more in the 
treatment group. The treatment group patients were characterized by moderate symptoms 
of anxiety, no symptoms of depression and normal function at home at the time of the 
study follow-up visits.  This suggests that patients in the treatment group showed 
important improvements in their symptoms of depression and impaired function at home 
over time. Patients in the control group showed higher probabilities of belonging to the 
latent class that reported both psychiatric disorders and impaired function at home (latent 
class I) and the latent class that reported both psychiatric disorders and normal function at 
home ( latent class II) over time. In summary, when comparing the symptomatology 
profiles of the treatment and control group, patients in the treatment group showed 
important improvements in their symptoms of depression and function at home, with 
moderate persistence of anxiety. These findings showed that symptoms of depression and 
Change in Symptomatology Profiles        
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impaired function persisted over time in the control group.  In this randomized controlled 
trial this difference between the two groups is likely due to the effect of CBT.  
          Our results showed a significant effect of CBT in the treatment group, with the 
highest effect observed between baseline and the second month of follow-up. This effect 
is important to consider when deciding the type and timing o f implementing an 
intervention in patients with an ACS. Moreover, our results demonstrated that women 
reported a higher response to CBT showing a more significant remission of symptoms 
linked to depression, anxiety and func tion than men. Our findings also demonstrated that 
women were more likely to transition from latent classes I and II (those that reported 
depression and anxiety with or without impaired function) to latent class III (moderate 
anxiety only). These results may be explained by the effect of CBT on depression and 
function in women.   
Effects of CBT on Depression and Anxiety in Patients with an ACS 
          Prior research has shown that depression, anxiety and function persist over time in 
patients with an ACS, and treatment response to CBT is still controversial.  Results 
reported from one of the largest studies of patients with an ACS and with symptoms of 
depression, the ENRICHD trial, were somewhat mixed. Improvement in the assessed 
depressive symptoms were reported at the six-month evaluation for patients receiving 
CBT in comparison with the control group, but this improvement did not persist at the 
30-month evaluation 11. Similar results were described in another study conducted by 
researchers at the Montreal Heart Institute 20. A group of 1376 post- myocardial 
infarction (MI) patients (30 % women) were randomly assigned to usual care or a phone-
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intervention program which consisted of emotional support, education and practical 
advice. The intervention was administered monthly for a year period. The goa l of this 
program was to reduce psychological distress that followed the occurrence of myocardial 
infarction. The authors reported no significant changes on depression and anxiety after 
one year of follow-up. These researchers reported that women showed a significant 
negative response to the intervention. Women showed worsening of depressive 
symptoms in the treatment group when compared to men over time.   
          It is important to take into account when comparing these two studies to our 
findings that our sample was smaller, and the follow-up pe riod w as shor ter than the 
ENRICHD and the Montreal studies. O ne important strength of our study is the use of 
latent transition modeling, which allowed us to conduct modeling of depression and 
anxiety subscale scores of the HADS and home function joint ly. D ue to the co-
occurrence of these psychiatric disorders and function in patients with an ACS, we 
believe that combining information from these three indicators may help us to obtain a 
more accurate assessment of the effectiveness of the intervention in multiple domains, 
namely remission of symptoms of anxiety, depression and function over time. 
 Study Strengths and Limitations
         Latent transition models have some important strengths in cases in which it is 
appropriate to think of the underlying phenomenon of interest in discrete terms. One 
important strength is that examining the prevalences of the latent classes and the 
transitions from the one latent class to another provides a detailed look at change over 
time that is difficult to ob tain in continuous data analyses14-15. A latent class-based 
: 
  
61 
 
approach, in particular, can show very clearly whether a given status is particularly 
prevalent at certain times or for certain subgroups, whether individuals in a certain status 
are more or less likely to undergo a transition and whether there are qualitative 
differences between groups 14-15. From a policy and clinical’ point of view, a latent class-
based approach can help identify developmental periods in which interventions are mos t 
likely to be effective, and what behaviors should be the target of action at different time 
points.  
           Future longitudinal studies would benefit from longer duration of follow-up, a n 
increase in the number and variety of sites, and a larger and more representative sample. 
Patients with very severe depression/ anxiety and a lso patients who had received mental 
health care in the prior three months or had a diagnosis of substance abuse during the past 
year were excluded from this study. Thus, our findings may not apply to these high-risk 
individuals.   
         It would also be of importance to examine additional study outcomes such as 
frequency of re-hospitalizations after an ACS, compliance with medications, workplace 
performance, and other risk factors that can contribute to depression in patients after an 
ACS (e.g. social support, family involvement). Future studies examining patterns of 
change in these psychiatric disorders and function as they are related to clinical 
outcomes, response to CBT and other meaningful interventions, may provide a better 
understanding of how to approach and treat patients with an ACS and symptoms of 
depression and anxiety and impaired function 21.  
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         The implementation of statistical models such as latent transition analys is, that are 
not frequently used in clinical trials can help us to combine multiple indicators or 
multiple sources of information into one unique outcome in order to provide a more 
complete and multidimensional understanding o f  change over time. In our study, 
disregarding the high levels of correlation among depression, anxiety and impaired 
function in pa tients with an ACS over time may cause important information to be missed 
which may be crucial to understanding how and when an intervention should be 
implemented and in which populations to be most effective. 
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 Table 3.1: Patients characteristics 
VARIABLE CONTROL (N=34) TREATMENT (N=45) 
Age (mean, years) 60.7 59.9 
Female (%) 35.3 31.1 
White (%) 88.1 88.9 
History of Ischemic Heart Disease (%) 47.8 40.0 
Length of hospital stay (mean, days) 3.1  3.6 
Major Depression History (%) 29.4 37.8 
HADS Depression Scores (mean) 6.5  8.5  
HADS Anxiety Scores (mean) 7.1  8.1  
Workplace social adjustment: Work(mean) 3.8 3.6 
Workplace social adjustment: Home(mean) 3.0 3.1 
 
 
Table 3.2: Fit statistics for the latent class models  
Model tested Bayesian Information 
Criterion (BIC) 
Akaike Information 
Criterion (AIC) 
G2 Log-
Likelihood 
Degrees of 
Freedom 
2 class 547.09 500.48 460.48 -494.47 8171 
3 class 613.78 499.58 401.58 -465.02 8142 
4 class 741.80 532.03 352.03 -440.25 8101 
In bold: 3 class model selected for this study 
 
 
Table 3.3: Item-response probabilities for having anxiety, depression and impaired 
function for each latent class 
 Latent Status I Latent Status II Latent Status III 
Anxiety 0.79 0.75 0.37 
Depression 0.94 1 0.05 
Dysfunction 0.84 0 0.05 
Latent Status I=Depression, anxiety & dysfunction; Latent Status II=Depression & anxiety; Latent Status 
III=Anxiety 
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Figure 3.1-A Membership probabilities for the different latent classes by treatment group 
at each time point: Control group 
 
 
 
 
Figure 3.1-B: Membership probabilities for the different latent classes by treatment group 
at each time point: Treatment group 
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Table 3.4: Transition probabilities by treatment group                                 
 Control Treatment 
 Month 2 
 
 
 
 
Baseline 
 Latent 
Status I 
Latent 
Status II 
Latent 
Status III 
Latent 
Status I 
Latent 
Status II 
Latent 
Status III 
Latent Status I 0.60 0.39 0 0.59 0.14 0.27 
Latent Status II 0.42 0.47 0.11 0 0.35 0.65 
Latent Status III 0.14 0.34 0.52 0.09 0.50 0.41 
 Month 3 
 
 
 
 
Month 2 
 Latent 
Status I 
Latent 
Status II 
Latent 
Status III 
Latent 
Status I 
Latent 
Status II 
Latent 
Status III 
Latent Status I 0.88 0 0.12 0.58 0.36 0.06 
Latent Status II 0.01 0.94 0.05 0.11 0.89 0 
Latent Status III 0 0 1 0.13 0 0.87 
 Month 6 
 
 
 
 
Month 3 
 Latent 
Status I 
Latent 
Status II 
Latent 
Status III 
Latent 
Status I 
Latent 
Status II 
Latent 
Status III 
Latent Status I 0.61 0.22 0.17 0.59 0.32 0.09 
Latent Status II 0.19 0.81 0 0.09 0.74 0.17 
Latent Status III 0 0 1 0 0.19 0.81 
*Transition probabilities are estimated conditional on the previous time point only; they sum to 1.0 across 
rows;  Latent Status I=Depression, anxiety & dysfunction; Latent Status II=Depression & anxiety; Latent 
Status III=Anxiety  
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Background: Patients with an acute coronary syndrome (ACS) and symptoms of 
depression and anxiety report a worse quality of life than pa tients without these disorders. 
Identifying symptom profiles of patients with depression and anxiety will not only better 
inform clinical management by improving diagnostic practices but also help to refine 
treatment strategies in these patients.  
Objectives: To determine symptom profiles of depression and anxiety in ACS patients 
using the hospital anxiety and depression scale (HADS). A secondary study objective 
was to examine the effects of age and sex on patients’ symptom profiles.  
Methods: A total of 100 ACS patients with mild to severe depression and/or anxiety at 
one month pos t-hospital discharge were enrolled in a randomized trial of cognitive 
behavioral therapy. Latent class and latent transition analyses were used to identify 
symptomatology profiles of depression and anxiety.   
Results: A two-class solution was selected to describe depression and anxiety 
symptomatology profiles. Class I (76% of patients at baseline) was labeled “severe 
depression and some anxiety”.  Class II (24% of patients at baseline) was labeled “mild 
depression and distress anxiety”. Approximately 25% of patients in the treatment group 
transitioned to the less severe depression and anxiety class compared to 10% in the 
control group at the time of the month-two of follow-up; nearly 50% of patients in the 
control group showed worsening of symptoms as compared to 28% in the treatment 
group. There were no sex differences in the probability of transitioning from one class to 
the other.  More than 70% of older patients (> 60 years old) continued to have severe 
depression and anxiety at the 2-months follow-up contact.  
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  Conclusions: The results of the current study stress the importance of assessment of 
depression and anxiety and follow-up o f pa tients after an ACS.  F urther research should 
examine the association of depression and anxiety after an ACS with patient’s age and 
determine whether these psychiatric disorders affect subsequent morbidity and mortality 
in older as compared to younger patients and the reasons for possibly different results  
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       Patients with an acute coronary syndrome (ACS) experience considerable stress in 
adjusting to living with their illness.  Thus, it is not surprising that depression and anxiety 
are more prevalent in this group of patients than in the general pop ulation 1-6.  Patients 
with an ACS and symptoms of depression and anxiety not only experience higher rates of 
long-term morbidity and mortality but also report a worse quality of life than patients 
without symptoms of these psychiatric disorders 3-5.  Due to the clinical and public health 
significance, as well as the economic burden of depression and anxiety in ACS patients, 
identifying symptom profiles of these psychiatric disorders will not only better inform 
clinical management by improving d iagnostic practices but will also help to refine the 
more optimal treatment of these high risk patients. The objectives of this study were to 
characterize the symptom profiles of depression and anxiety in patients with an ACS 
using the hospital anxiety and depression scale (HADS). A secondary study objective 
was to examine the effects of age and sex on these symptom profiles.  
          This study employed latent class analysis to identify classes of depression and 
anxiety in patients after an ACS with the goal of improving the diagnosis of symptomatic 
individuals and be tter representing the relative severity of diagnostic categories 7.  
Design and Methods: 
         The study sample consisted o f 100 patients hospitalized with an ACS in two 
coronary care units at a university hospital in Boston, MA, between September, 2001 and 
August, 2003 8,9.  Patients were 35 years and older at the time of  trial entry and had 
symptoms corresponding to mild to moderate levels of depression and/or anxiety as 
indicated by a score of seven or higher on either of the subscales of the Hospital Anxiety 
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Depression Scale (HADS).  None of the study pa tients had received mental health care in 
the prior three months, used a psychoactive drug during the past year, or were diagnosed 
with substance abuse during the past year.  Potentially eligible patients were identified by 
a research nurse through the review of hospital records and hospital census information. 
Patients were screened at approximately one month after hospital discharge for an ACS, 
and those meeting the predefined study inclusion criteria were randomly assigned to 
either cognitive behavioral therapy (CBT) or a typical-care control group 8, 9 . 
         Patient recruitment began during the index hospitalization for an ACS. Once 
patients consented to trial enrollment, the study coordinator administered the 14-item 
HADS by phone to assess symptoms of anxiety and depression. Subjects with scores 
between 7 and 15 on either the anxiety or depression scale were enrolled into the trial and 
randomized into the intervention or usual care comparison groups 8, 9.         
         The trial intervention consisted of a series of CBT sessions that helped patients 
identify and manage the challenges of living with a chronic condition 8.  Patients in the 
control group received information on coping with cardiac disease.  Baseline survey 
assessments (within 30 da ys of hospital discharge) included the Primary Care Evaluation 
of Mental Disorders (PRIME-MD), the Work and Social Adjustment Scale (WSAS) and 
the Hospital Anxiety and Depression Scale (HADS), the primary outcome measure 8.  
The study protocol was reviewed and approved by the institutional review board of the 
participating hospital. 
Data Collection Protocols  
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         Data were collected at the time of baseline enrollment for the HADS using 
interactive voice recognition (IVR). Patients completed the HADS at the time of the two, 
three, and six month follow-up visits. An aggressive follow-up system was used to 
enhance survey response rates, which consisted of reminder postcards, telephone call 
reminders, and re-mailing o f questionnaires. Data reported for the present study were 
collected at baseline and at the time of the two-month follow-up. Further analysis was 
performed on data from the four- and s ix-month follow-ups, but the results did not differ 
from those in the two-month follow-up.  
         The HADS contains seven questions to assess depression and seven to assess 
anxiety. Each scale is scored from 0 to 21; scores between four and seven represent 
subclinical depression whereas patients who scored eight or higher were classified as 
being ‘‘depressed’’. The same criteria and scores were used for diagnosing anxiety. One 
important advantage of using the HADS is that this scale focuses on cognitive rather than 
somatic constructs which minimizes the likelihood t hat somatic symptoms of ACS will 
be attributed to depression. 
Assessment Instrument 
         In the current study, instead o f considering the diagnosis of depression and anxiety 
as binary indicator, all the 14 items of the HADS were used as indicators of depression 
and anxiety symptoms. Each item was dichotomized and included individually in the 
analysis.  
Data Analysis 
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         Descriptive analyses on patient’s baseline characteristics at the time of trial entry 
were performed; t-tests and chi-square tests, as appropriate, were used to examine 
possible differences in baseline continuous and categorical variables between patients 
randomly assigned to the intervention and control groups.  
         Latent class analysis and latent transition analysis were used to identify subgroups 
of patients with similar patterns of depression and anxiety symptoms and to describe 
changes over time in subgroup membership. Latent class analysis identifies a set of 
mutually exclusive and exhaustive latent classes characterized by similar patterns of 
responses 10-11.  Latent transition analysis is a longitudinal extension of latent class 
analysis that additionally models change over time in class membership10-11. Latent class 
and latent transition analysis are measurement models that separate measurement error 
from other aspects of the model. Latent class analysis estimates two sets of parameters. 
Item-response probabilities estimate the probabilities of responding positively and 
negatively to the HADS items given class membership. Latent class membership 
probabilities estimate the distribution of the classes. The 14 items of the HADS were 
used as indicators of depression and anxiety and were re-coded such that one represented 
never or rarely ever experiencing the symptom whereas the other code represented 
experiencing the symptom sometimes or most of the time. Thus, because the items were 
dichotomized and the HADS has 14 indicators, there were more than 16, 000 possible 
patterns of response (214= 16384).  Statistical indices of goodness of fit included: the 
Akaike information criterion (AIC), Bayesian information criterion (BIC) and G2. 
Results:  
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          The control and intervention groups were well balanced with respect to a variety of 
baseline patient characteristics (Table 1); both groups were predominantly comprised of 
white, older males.  Average depression and anxiety scores were slightly higher for the 
intervention group at baseline but the differences were not statistically significant.      
         Latent class analysis was used to identify the most common anxiety and depression 
symptom profiles in patients after an ACS. Models with two and three latent classes were 
fit and compared at baseline; selection of the optimal model considered goodness of fit 
and parsimony using various statistical fit indices. In order to ensure that the maximum 
likelihood solution was identified for both models, 100 sets of random starting values 
were used to examine potential solutions.   
Latent Class Analysis: Fitting and Description of the Classes 
         Based on the fit indices and stability of the models, a two-class solution was 
selected (Table 2). Although the AIC was somewhat lower in the three-class model, it 
was less stable than the two-class model. In addition, the BIC was higher for the three-
class mode l than the two-class model.  
         Table 3 describes the 14 items assessed by the HADS. In the selected two-class 
solution, Class I (76% of patients at baseline) was termed “severe depression and some 
anxiety”; this class was characterized by a pattern of item-response probabilities that 
indicated many symptoms of depression and some symptoms of anxiety for class 
members.  Class II (24% of patients at baseline) was termed “mild depression and 
distress anxiety”. This class was characterized by a pattern of item- response probabilities 
that indicated milder symptoms of depression and symptoms of distress anxiety. To aid 
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the interpretation of these data, the estimated item-response probabilities are plotted in 
Figure 1. Class I had higher probabilities of experiencing negative anticipation, panic, 
lack of enjoyment, and general symptoms of anhedonia. Class II, on the other hand, had 
higher probabilities of experiencing worrying thoughts but they can still sit and relax, and 
they did not refer any symptoms related to anhedonia. 
         Latent class analysis was also used to examine the structure of the classes at the 
time of the two month follow-up contact. The class structure appeared to be similar, but 
the distribution of the classes was different, as patients changed class membership over 
time.  Patient change over time is discussed be low in the context of the latent transition 
mod el. 
         A Latent transition model was used to examine change over time from baseline to 
follow-up. Two- and three-class models were fit and compared to confirm that the two 
classes identified with latent class analysis were adequate. Model identification was again 
checked using 100 sets of random starting values. Model comparison and confirmation 
was based on the log- likelihood ratio. The G2 fit statistic was not computed for this 
mod el, because the number of possible response patterns was very large (i.e., 14 items 
measured at multiple times).   
Latent Transition Analysis: Fitting and Description of the Classes 
         The two-class solut ion with a log- likelihood of -1032.01 was identified 88% of the 
time. Estimation of the three-class model was less stable, and the solution with a log-
likelihood of - 999.74 was identified only 24 % of the time. The instability of the three-
class solution, combined with the results of the latent class analysis discussed above, led 
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to the selection of the two-class solution as the best at balancing model fit and parsimony 
in the description of the da ta.  
          Class I (55% of patients at baseline and 64% of patients at follow-up) was 
characterized by a similar pattern of item-response probabilities to the one from the latent 
class analysis. It was again labeled as “severe depression and some anxiety”.  C lass II 
(45% of patients at baseline and 36% of patients at follow-up) was also characterized by 
a similar pattern of item-response probabilities to the one from the latent class analysis. It 
was again labeled as “mild depression and distress anxiety”. To aid interpretation, the 
estimated probabilities are plotted in Figure 2. It should be noted that differences between 
the latent class and latent transition analysis results may be due to a variety of reasons, 
including different amounts of power in the two-models and high standard errors of the 
parameter estimates with the small sample size of the current study.  
          To examine change over time in patient class membership, latent transition analysis 
was used to estimate the probabilities of transitioning between classes. About 86% of 
patients with severe depression and some anxiety at baseline continued to have similar 
symptoms at the two-month follow-up contact.  Among the patients with mild depression 
and anxiety at baseline, 41% reported a worsening of symptoms to severe depression and 
some anxiety at the two month follow-up contact.   
Latent Transition Analysis: Transitions Between Latent Classes 
Latent Transition Analysis: Examining Treatment Related Effects
         Treatment group was included in the latent transition analysis as a grouping 
variable in the follow-up analyses to determine the effects of treatment on change in 
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patients’ symptom profile over time.  Patients receiving the intervention showed some 
improvement in their symptom profile, as approximately 26% of treated patients 
transitioned from the more severe to the less severe depression and anxiety class. In 
comparison, less than 10% of the patients in the control group made the transition from 
more severe depression and anxiety class to less severe class. In addition, 72% of patients 
in the treatment group remained in the less severe depression and anxiety class over time, 
compared to 51% of patients in the control group.  
         The effects of sex and age on patients’ symptom profiles of depression and anxiety 
after an ACS were examined in the follow-up analyses.  The effect of sex was 
investigated by including sex into the latent transition analysis as a grouping variable to 
compare class membership probabilities and transitions for women compared with men. 
The probabilities of membership in the classes at baseline were non-significantly 
different for males and females (p-value=0.77 ) (Table 4) and the intervention was not 
hypothesized to work differently for males and females.  
Latent Transition Analysis: Examining the Effect of Sex and Age 
         Similarly, the effect of age was investigated by including age into the latent 
transition analysis as a grouping variable. Patients were split into two groups, younger (< 
60 years old) and older (60 years and older). Table 5 reports the latent class membership 
probabilities by age group. Baseline differences in the probabilities of latent class 
membership for younger versus older patients were borderline significant (p-value=0.07).  
          All younger patients who reported severe depression and some anxiety at baseline 
remained in the same class at the time of follow-up.  In comparison, about 74% of older 
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patients remained in the severe depression and some anxiety class. In addition, 31% of 
younger patients with mild depression and d istress anxiety transitioned to the more severe 
depression and anxiety class whereas almost 60 % of older patients made that transition.  
Discussion 
         The results of the present study suggest that two clinically relevant classes of 
symptoms of depression and anxiety in patients with an ACS can be identified.  Class I, 
labeled as “severe depression and some anxiety” had a higher prevalence at baseline and 
month two of follow-up (55% and 64% respectively) than Class II, labeled as “mild 
depression and distress anxiety”. Moreover, another important finding was that more than 
40% of patients who reported “mild depression and distress anxiety” at baseline 
transitioned to the “severe depression and some anxiety” class at the time of the two-
month follow-up visit. These results emphasize the importance of the assessment of 
depression and anxiety in pa tients after an ACS not only at the time of their acute event 
but over a more extended follow-up period. 
Two Latent Class Model to Identify More Prevalent Symptoms of Depression and 
Anxiety 
         Regarding the particular items assessed by the HADS, it is important to highlight 
the presence of anhedonia as a key factor differentiating the two symptom profile classes. 
Patients that endorsed the “severe depression and some anxiety” class gave a positive 
answer to all the questions that assessed anhedonia in the HADS, whereas patients that 
endorsed the “mild depression and distress anxiety” class did not report any major signs 
of anhedonia.  
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         Other researchers have stressed the importance of anhedonia in patients after an 
ACS as a predictor of cardiac mortality 12.  The results of one study conducted in 40 
hospitals in Ireland investigated the use of the HADS and the Beck depression scale in 
assessing one-year mortality risk in a national sample of patients after an ACS. 
Depression, as measured by the HADS, but not by the Beck scale, was associated with an 
increased risk of dying within one-year 12.  The HADS concentrates on anhedonia, 
whereas the Beck scale focuses on psychiatric criteria for a major depressive disorder.  
These findings underline the importance on detecting specific symptoms that are key 
items, such as anhedonia, in the diagnos is of depression and anxiety in patients after an 
ACS. Early diagnosis and subsequent treatment of these symptoms may improve 
morbidity and mortality in this group of high-risk patients 12. 
           In contrast, items related to anxiety were not as clear as items related to depression 
in being able to differentiate the two symptoms profile classes. Notably,  patients that 
endorsed the latent class that reported “mild depression and distress anxiety” tended to 
report more signs of general distress than patients that belonged to the “severe depression 
and some anxiety” class.  
          The inclusion of treatment as a covariate supplied important information for the 
determination of the effect of treatment in patients’ symptom profiles. Patients receiving 
the intervention showed improvement in their symptom profiles of depression and 
anxiety at month-two of follow-up; a higher percentage of patients in the treatment group 
transitioning to the less severe depression and anxiety class as compared to those in the 
Effects of Treatment on Determining Symptom Profiles of Depression and Anxiety 
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control group. In addition, an important percentage of patients that received CBT 
remained in the less severe depression and anxiety class at month-two of follow-up, as 
compared to the control group. These findings demonstrate the effect of the intervention 
not only in the improvement of symptoms of depression and anxiety after an ACS but 
also in the prevention of these symptoms later on in the follow-up period. Considering 
the important association of depression and anxiety and higher morbidity and mortality in 
patients after an ACS, CBT should be considered as an important treatment option to 
improve clinical management in patients after an ACS. 
         The inclusion of these demographic covariates provided valuable information for 
the identification of the two classes of symptom profiles. An important association was 
observed between the “severe depression and some anxiety” class and patients’ age.  
Older patients were more likely to report severe symptoms of depression and anxiety than 
younger patients bo th at baseline and over the two-month follow-up.  Other researchers 
have stressed the importance of assessing depression in older patients after an ACS 13.  In 
a study of  more than 100 patients 65 years and older who were released from the hospital 
a month after an ACS, the Beck and the Standard C linical Interview for the Diagnostic 
Statistical Manual of Mental Disorders, Third Edition, Revised (SCID) were completed at 
the time of baseline enrollment 13.  Older patients with depression were more likely to die 
during the first four months than older patients without depression 13.   
Effects of Age and Sex on Determining Symptom Profiles of Depression and Anxiety 
          This finding has important implications in terms of allocation of resources for the 
assessment and treatment of depression and anxiety in older patients after an ACS. Older 
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patients with symptoms of depression and anxiety after an ACS may benefit from more 
specified diagnostic and treatment programs. Further research should examine the 
association of depression and anxiety after an ACS and patient’s age and determine 
whether these psychiatric disorders affect subsequent morbidity and mortality in older as 
compared to younger patients.  
         There were no significant differences between the symptoms of depression and 
anxiety in men and women.  A note of caution should be taken here in the interpretation 
of these results, because the sample was fairly small. Future studies would benefit from 
an increase in the number and variety of sites, and a larger and more representative 
sample.  
         This study also highlights the utility of latent class and latent transition analysis in 
elucidating symptom profiles of depression and anxiety in patients after an ACS.  The 
results demonstrate that depression and anxiety after an ACS tend to occur together, thus 
treatment of this group of high-risk patients needs to take into account the interplay of 
these two psychiatric disorders 12. The findings also stress the importance of assessment 
and follow-up of patients after an ACS. An important challenge in clinical practice is to 
improve the quality of life of patients with a chronic illness such as an ACS. In as much, 
developing strategies for rapidly detecting and managing those at increased risk is an 
essential step in overcoming this challenge.  
         This study has several limitations that must be kept in mind in interpreting the 
results. Patients with very severe depression/ anxiety, patients who had received mental 
Study Strengths and Limitations 
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health care in the prior three months and those who had a diagnosis of substance abuse 
during the past year were excluded from this study. Thus, the find ings  may not app ly to 
these high-risk individuals.  Another limitation is the shor t duration of follow-up and 
small sample size. Latent class and latent transition analysis have several strengths. They 
combine the cross-sectional measurement and the longitudina l description of change in 
categories of the latent variable over time, and have considerable flexibility in describing 
progression and stability, providing a detailed examination of change over time that is 
difficult to obtain in continuo us data analyses 11. Identifying symptom profiles of 
depression and anxiety in patients after an ACS may improve diagnostic practices and 
refine treatment of these patients 
          The current study demonstrates that patients with depression and anxiety after an 
ACS can be identified on the basis of the symptoms that they present. This is particularly 
important to identifying individuals at potential risk for developing clinical complications 
after an ACS.   
Conclusions  
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Table 4.1:  Characteristics of study participants 
VARIABLE TREATMENT (N=45) CONTROL (N=34) 
Age (mean, years) 59.9 60.7 
Female (%) 31.1 35.3 
White (%) 88.9 88.1 
Major Depression History (%) 37.8 29.4 
HADS Depression Scores (mean) 8.5  6.5  
HADS Anxiety Scores (mean) 8.1  7.1  
 
 
 
 
Table 4.2: Goodness of fit indices for the latent class analysis for the 2 and 3 class model 
 
 G2 AIC BIC Fqcy 
2-class model 480.11 538.11 607.19 100 
3-class model 435.57 523.57 628.38 32 
 
 
 
Table 4.3: Items of the HADS 
 
QUESTION  Class I Class II 
1-I feel tense or 'wound up' (A) 0.09 0.44 
3-I get a sort of frightened feeling as if something awful is about to 
happe n (A) 
0.76 0.38 
5-Worrying thoughts go through my mind (A) 0.21 0.67 
7-I can not sit at ease and feel relaxed (A) 0.15 0.77 
9-I get a sort of frightened feeling like 'butterflies' in the stomach (A) 0.95 0.69 
11-I feel restless as I have to be on the move (A) 0.27 0.55 
13-I get sudden feelings of panic (A) 0.97 0.67 
2-I do not enjoy t he things  I used to enjoy (D) 0.06 0.51 
4-I can not laugh and see the funny s ide of things  (D) 0.03 0.3 
6-I do not feel cheerful (D) 0.09 0.53 
8-I feel as if I am slowed down (D) 0.45 0.75 
10-I have lost interest in my appearance (D) 0.96 0.85 
12-I do not look  forward with enjoyment to things  (D) 0.14 0.76 
14-I cannot enjoy a good book or radio or TV program (D) 0.02 0.3 
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Figure 1: Latent class profile plot of the 14- items for the HADS baseline only 
 
 
 
 
 
 
Figure 2: Latent class profile plot of the 14- items for the HADS baseline and month-2 
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Table 4.4: Membership probabilities by sex at baseline and month-2 of follow-up 
 
 Latent Class I Latent Class II 
Male Female Male Female 
Baseline 0.578 0.528 0.422 0.471 
Month-2 0.643 0.649 0.356 0.350 
 
 
 
 
 
Table 4.5: Membership probabilities by age at baseline and month-2 of follow-up 
 
 Latent Class I Latent Class II 
Younger Older Younger Older 
Baseline 0.404 0.742 0.596 0.278 
Month-2 0.588 0.700 0.412 0.299 
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Chapter V 
Conclusions 
The purpos e of the current dissertation was to illustrate the application of advanced 
statistical techniques to research questions related to depression and anxiety in patients 
with an ACS.   
Chapter II: Depression and Anxiety after an Acute Coronary Syndrome: a 
Bivariate Mixed Model Approach 
          The aims of this study were to determine trajectories of depression and anxiety 
after an ACS, to examine the effects of cognitive behavioral therapy (CBT) on depression 
and anxiety, and to determine if anxiety and depression symptoms change at the same 
rate with CBT treatment as indicated by joint modeling o f these two psychiatric 
disorders.   
          The principal findings of this study suggested that depression and anxiety are 
highly correlated and pe rsistent in patients with an ACS both at baseline and over the six 
month follow-up period. The intervention utilized in the parent RCT does not appear to 
uncouple the association between anxiety and depression, suggesting that CBT has 
comparable effects on both psychiatric disorders.  
          Bivariate mixed models are of particular importance in understanding multi-
dimensional profiles of psychopathology in patients with mental disorders who typically 
demonstrate multiple maladaptive behaviors, a variety of symptoms, and decrements in 
various domains of function, each of which are often highly correlated. A better 
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understanding o f the relative contributions of these various, and inter-dependent, 
phenomena with regards to patients’ symptoms and functionality, could inform 
appropriate targets for interventions to achieve a better quality of life in patients after an 
ACS. Future research needs to investigate the roles of anxiety and depression, as well as 
other indicators of quality of life such as perceived level of stress, and ways of coping 
with stressful events, as a joint phenomenon in order to more precisely clarify the effects 
of these psychiatric disorders on mortality, morbidity, and quality of life in patients after 
an ACS. Additional studies are also needed to compare the effectiveness, and cost-
effectiveness of CBT, and o ther interventions targeting both psychiatric disorders jointly.  
Chapter III: Identifying Classes of Response to Treatment of Depression, Anxiety, 
and Functional Status in Patients After an Acute Coronary Syndrome 
          The objectives of this study were to (1) identify symptomatology profiles of 
depression, anxiety, and functional impairment among patients with an ACS; (2) describe 
changes over time in symptomatology profile; and (3) determine if patients receiving 
CBT showed signs of remission in depression, anxiety, and impaired function earlier than 
patients that received usual care. In addition, the associations between symptomatology 
profile and age, gender, and lengt h of stay in the hospital were examined.   
         The results of my second paper indicate that a three-class solution was selected to 
describe symptomatology profiles of patients with an ACS and symptoms of depression 
and anxiety. One class was characterized by patients with both psychiatric disorders and 
impaired function (as manifest by the presence of symptoms of anxiety, depression, and 
impaired function at home),  the second by patients with psychiatric disorde rs but normal 
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function, and the third by patients with anxiety, but without depression, and having 
normal function. As compared to a control group receiving usual care, patients who 
received CBT reported higher rates of symptomatology remission.  The results showed a 
significant effect of CBT in the treatment group, with the highest effect observed between 
baseline and the second month of follow-up. Latent class and latent transition approach 
clarifies periods during which an intervention is most likely to be effective in patients 
with depression and anxiety after an ACS. Moreover, our results suggest that future 
studies examining pa tterns of change in these psychiatric disorders and function as they 
are related to clinical outcomes such as frequency of re-hospitalizations after an ACS, 
compliance with medications, response to CBT and other meaningful interventions may 
provide a better understanding of how to approach and treat ACS patients with 
psychiatric disorders and impaired function 21.  
Chapter IV: Profiling Symptoms of Depression and Anxiety in Patients with an 
Acute Coronary Syndrome Using Latent Class and Latent Transition Analysis 
         The objectives of this study were to determine the symptom profiles of depression 
and anxiety in patients with an ACS using t he hospital anxiety and depression scale 
(HADS). A secondary study ob jective was to examine the effects of age and sex on these 
symptom patterns. 
         The results of my third paper indicate that a two-class solution was selected to 
describe depression and anxiety symptomatology profiles. Models including from two to 
five latent classes were fit and compared based on the sample size and wellness of fit.   
Class I was labeled “severe depression and some anxiety”.  Class II was labeled “mild 
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depression and distress anxiety”.  Regarding the particular items assessed by the HADS, 
the presence of anhedonia was a key factor differentiating the two symptom profile 
classes. Patients that endorsed the “severe depression and some anxiety” class gave a 
positive answer to all the questions that assessed anhedonia, whereas patients that 
endorsed the “mild depression and distress anxiety” class did not report this symptom. 
More than 70% of older patients (> 60 years old) continued to have severe depression and 
anxiety at the 2-months follow-up contact.  
          The results of the current study stress the importance of assessment of depression 
and anxiety and follow-up o f patients after an ACS.  Further research should examine the 
association of depression and anxiety after an ACS with patient’s age and determine 
whether these psychiatric disorders affect subsequent morbidity and mortality in older as 
compared to younger patients and the reasons for possibly different results.  This study 
also highlights the utility of latent class and latent transition analysis in elucidating the 
symptom profiles of depression and anxiety in patients after an ACS.  This is particularly 
important in identifying individuals at potential risk for developing clinical complications 
after an ACS. This finding has important implications in terms of allocation of resources 
for the assessment and treatment of depression and anxiety in patients after an ACS 
Strengths and Limitations of Present Study 
         This study has several limitations that future longitudinal studies would benefit 
from. These include the need for a longer duration of follow-up, a n increase in the 
number and variety of participating s tudy sites, and a larger and more representative 
patient population. Patients with very severe depression/ anxiety, and patients who had 
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received mental health care in the prior three months or had a diagnosis of substance 
abuse during the past year, were excluded from this study. Thus, our findings may not 
apply to these high-risk individuals.   
          Latent class and latent transition analysis have several strengths. They combine the 
cross-sectional measurement and the longitudinal description of change in categories of 
the latent variable (e.g. distress due to a chronic illness) over time, and have considerable 
flexibility in describing progression and stability of this variable, providing a detailed 
examination of change over time that is difficult to ob tain with more traditional data 
analyses procedures. Another important advantage of these models is that they allow 
investigators to examine the impact of the intervention, in this case CBT, on changes in 
depression and anxiety simultaneously.  A latent class-based approach, in particular, can 
clearly show whether a given status is particularly prevalent at certain times or for certain 
subgroups, whether individuals in a certain status are more or less likely to undergo a 
transition, and whether there are significant differences between respective comparison 
groups. 
 
Final Conclusions 
         This study highlights the application of advanced statistical techniques in 
examining depression and anxiety in patients after an ACS.  Joint modeling of related 
outcomes such as those studied in this investigation promise to be  very useful in 
determining the changes over time in an outcome, since these psychiatric disorders are 
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highly related to each other. The findings also stress the importance of assessment and 
follow-up of patients after an ACS.  
The implementation of statistical models, such as latent transition analysis, that 
are infrequently used in clinical trials can help us to combine multiple indicators,  or 
multiple sources of information,  into a unique composite outcome in order to provide a 
more complete and multidimensional understanding of  changes in relevant factors over 
time. In the present study, d isregarding the high levels of correlation between depression, 
anxiety,  and impaired function in patients with an ACS over time, may result in 
important information being missed which may be crucial to understanding how and 
when an intervention should be implemented and in which populations to be most 
effective. 
         This study provides support for the idea that patients with depression and anxiety 
after an ACS can be identified on the basis of the symptoms that they present with. This 
is particularly important for identifying individuals at high risk for developing clinically 
significant complications after an ACS such as repeat hospitalizations, as well as poor 
medication adherence and premature mortality. In addition, the results of the present 
study illustrate the application and importance of latent class and latent transition analysis 
in identifying profiles of depression and anxiety in these high risk-patients. Identifying 
symptom profiles of depression and anxiety in patients after an ACS may improve 
diagnostic practices and refine the treatment of these patients.  
         The current study suggests that future research needs to carefully examine, through 
use of advanced statistical models, how the different aspects of depression and anxiety 
  
91 
 
after an ACS affect subsequent morbidity and mortality in patients after an ACS.  Further 
prospective studies should focus on the presence of depression and anxiety after an ACS 
and its association with several clinical outcomes such as recurrent myocardial infarction 
and other cardiac complications, readmission to the hospital, compliance with cardiac 
medications, and other factors in the year following the ACS episode and compare the 
results for the different age groups and gender. An important challenge in clinical 
practice is to improve the quality of life of patients with a chronic illness such as an ACS. 
In as much, developing strategies for rapidly detecting and managing these high risk-
patients is an essential first step in overcoming this challenge and improving the long-
term prognosis and quality of life of these patients. 
 
.  
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